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ABSTRACT 
 
The hyperbilirubinemic jj Gunn rat is a well established animal model for Crigler-
Najjar type I Syndrome and neonatal jaundice. Similarly to humans, they present 
neurological deficits and what is more a marked cerebellar hypoplasia with a prominent 
loss and degeneration of Purkinje cells and granule neurons. Since high levels of bilirubin 
have been proven to arrest the cell cycle progression, we addressed the question if the 
cerebellar hypoplasia observed in the hyperbilirubinemic Gunn rat could be somehow 
linked to a cell cycle arrest, and if this cell cycle arrest was affecting selectively primary 
cultures of astrocytes and cerebellar granule neurons. 
In the in vivo study we report that the high levels of bilirubin present in the cerebellum 
of hyperbilirubinemic Gunn rat cause a cell cycle arrest in the late G0/G1 phase, 
characterized by a decrease in the protein expression of Cyclin D1, Cyclin A, Cyclin A1 
and most importantly Cdk2. Meanwhile an increase in protein expression of total Cyclin 
E, due to a rose in the levels of low molecular weight Cyclin E forms (a supposed attempt 
to bypass the cell cycle arrest), was in vain. 
Furthermore, we observed an increment in the 18 kDa fragment of Cyclin E 
(implicated in the amplification of the apoptotic pathway) suggesting us the presence of 
an increased apoptosis. Consistent with this speculation, the levels of the cleaved form of 
Poly (ADP-ribose) Polymerase (PARP-1) were increased. 
In the in vitro study we support the selectivity of bilirubin to damage specific cells as 
cerebellar granule neurons. Cerebellar granule cells viability was more affected respect to 
astrocytes in the same treatment conditions. The cell cycle was affected by high 
concentration of bilirubin only in cerebellar granule cells. 
We hypothesised that the characteristic cerebellar hypoplasia of hyperbilirubinemic 
Gunn rat may be due to the conjunction between cell cycle arrest and apoptosis, and that 
these two processes are intimately connected. Furthermore, only granule neurons cell 
cycle was affected. 
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Cryopreservation has been used routinely in prolonged storage of many mammalian 
tissues. The cryopreservation of neural cells/ tissue started to be interesting after the 
successful transplantation of such tissues, mainly for research. Several studies have been 
performed to achieve cryopreservation of granule cells, however, for these cell types 
there is no defined protocol for cryopreservation with sufficient success to enable it to be 
incorporated into routine clinical practice. As we were thinking to perform cerebellar 
granule cells transplantation as a way to treat Gunn rats cerebellar hypoplasia, we started 
to set up a protocol for cerebellar granule cells cryopreservation using the slow-freezing 
methodology. 
Cerebellar granule cells were successfully cryopreserved with a protocol that involves 
the use of 10 % of DMSO as cryoprotective agent, a freezing rate of 2.1°C/min, and a fast 
(154.4°C/ min) rewarming at 39°C. The cells cryopreserved in this way had a good cell 
viability and were kept in culture for 7 days. More experiments have to be made to 
standardize this protocol. 
 
xiii 
 
PUBLICATIONS 
List of publications 
Robert MC, Furlan G, Rosso N, Tiribelli C, and Gazzin S. Alterations in the cell cycle and apoptosis 
account for the cerebellar atrophy of hyperbilirubinemic Gunn rat pups. -In preparation- 
Gazzin S, Zelenka J, Zdrahalova L, Konickova R, Zabetta CC, Giraudi PJ, Berengeno AL, Raseni A, 
Robert MC, Vitek L, Tiribelli C. Bilirubin accumulation and Cyp mRNA expression in selected brain 
regions of jaundiced Gunn rat pups. 2012 Pediatric Research, Feb 15 doi: 10.1038/pr.2012.23. 
Robert MC, Gazzin S., Tiribelli, C. Bilirubin arrests the cell cycle in the Cerebellum of developing 
hyperbilirubinemic Gunn rat. FEBS Journal 2011, 278 (Suppl. 1), 274. 
Robert MC, Gazzin S, Berengeno A, Bellarosa C, Tiribelli C. Bilirubin modulates cell cycle in rat 
cerebella. Medicina 2010, Vol. 70 (Supl. II), 84. 
Berengeno A, Gazzin S, Bellarosa C, Robert MC, Tiribelli C. Does Bilirubin affect the ABCc (Mrp1) 
expression in the brain of the Gunn rat?. Pediatric Research Nov. 2010 (Supl. I), 300. 
 
Congress presentations 
Gambaro SE, Gazzin S, Robert MC, Tiribelli C. Study on the role of cytochrome P450 in bilirubin-
induced encephalopathy. In abstract of poster for International Symposium on Biology and 
Translational Aspects of Neurodegeneration. Venice, Italy. March 12-14, 2012. 
Robert MC, Gazzin S, Tiribelli C. Bilirubin arrests the cell cycle in the cerebellum of developing 
hyperbilirubinemic Gunn rat. In abstract of poster for 36
th
 FEBS Congress Biochemistry for 
Tomorrow’s Medicine, Torino, Italy. June 25-30, 2011. 
Robert MC, Gazzin S, Tiribelli C. Cell cycle alterations in hyperbilirubinemic Gunn rat cerebella. In 
abstract of poster for 7th Seminar Frontiers in Molecular Biology, Società Italiana di Biofisica e 
Biologia Molecolare (SIBBM), Trieste, Italy. May 26-28, 2011. 
Robert MC, Gazzin S, Berengeno A, Bellarosa C, Tiribelli C. Bilirubin modulates cell cycle in rat 
cerebella. In abstract of poster for LV Reunión Científica Anual de la Sociedad Argentina de 
Investigación Clínica (SAIC) Mar del Plata, Argentina. November 17-20, 2010.  
 xiv 
 
ABBREVIATIONS 
List of Abbreviations 
Ara-C Cytosine-β-D-arabino-furanoside 
Bf Free bilirubin 
BME Basal Medium Eagle with Earle’s salts, without L-glutamine 
BSA Bovine Serum Albumin 
CB Conjugated bilirubin 
CGC Cerebellar Granule Cell 
Cll Cerebella 
CNS Crigler- Najjar syndrome 
Ct Cycle Threshold 
div Days in vitro 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
FACS Fluorescence activated cell sorter 
FBS Foetal bovine serum 
FL Full length 
FSC Forward-scattered light 
jj Homozygous hyperbilirubinemic Gunn rats 
JJ Homozygous normobilirubinemic Gunn rats 
LMW Low molecular weight forms 
LN2 Liquid nitrogen 
MTT 3(4,5-dimethiltiazolil-2)-2,5 diphenil tetrazolium 
P Post-natal age in days 
Pi Propidium iodide 
RT Room Temperature 
SSC Side-scattered light 
UCB Unconjugated bilirubin 
UGT1A1 Uridine diphosphoglucuronate glucuronosyltransferase  
 
1 
 
1. INTRODUCTION 
 
1.1 Bilirubin 
1.1.1 Bilirubin metabolism 
Bilirubin is produced as end product of the degradation of the protoporphyrin portion 
of the heme group present in haemoglobin, myoglobin, and some enzymes. This 
breakdown generates 250 to 400 mg/day of bilirubin in humans (LONDON et al., 1950). 
More than 80 % of the bilirubin produced in human body derives from heme catabolism 
liberated from senescent red cells, 15-20 % from the turnover of myoglobin, cytochromes 
and other hemoproteins, and less than 3 % from destruction of immature red blood cells 
in the bone marrow (LONDON et al., 1950; Ostrow et al., 1962). 
The physiological degradation of heme group is mediated by the microsomal heme 
oxygenase enzyme, which is particularly abundant in spleen and liver, principal site of 
red cell breakdown. This enzyme directs the stereospecific cleavage of the α-methene 
bridge of heme group to form the linear tetrapyrrole, biliverdin, carbon monoxide, and 
iron (Tenhunen et al., 1968). This reaction is energy requiring, as the reduced form of 
nicotinamide-adenine dinucleotide phosphate (NADPH) and molecular oxygen (O2) are 
metabolized by cytochrome cP450 reductase to the oxidized form NADP (Yoshida and 
Kikuchi, 1978; Wilks and Ortiz de Montellano, 1993). Once synthesized biliverdin is 
converted to bilirubin (UnConjugated Bilirubin, UCB) by the cytosolic enzyme biliverdin 
reductase, in the presence of NADPH (Figure 1). 
As soon as bilirubin is released in the blood, and due to its lipophilicity, it must bind a 
carrier molecule to be transported to the liver, where it will be modified for its subsequent 
excretion. This function is accomplished by albumin that posses two binding sites for 
bilirubin. Almost all the bilirubin (99.9 %) present in plasma binds tightly but reversibly 
to serum albumin (Wennberg et al., 1979; Weisiger et al., 2001; Ahlfors, 2001). 
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Figure 1: Bilirubin metabolism. Bilirubin derives from heme metabolism by heme oxygenase and biliverdin reductase. 
 
When bilirubin-albumin complex reaches the liver, bilirubin is rapidly transferred 
from plasma into the liver. At the sinusoidal surface of the hepatocyte, bilirubin 
dissociates from albumin and is internalized, through mechanism not fully elucidated. It 
has been proposed that bilirubin is able to diffuse through cellular membranes (Zucker et 
al., 1999). There is also evidence that the hepatic uptake is saturable and occurs against a 
concentration gradient, supporting the idea of a protein-mediated transport mechanism 
(Cui et al., 2001). Within the aqueous environment of the hepatocyte, bilirubin is again 
bound to another group of carrier proteins, mainly to glutathione- S- transferases class 
alpha (ligandins) (Zucker et al., 1995). The binding to these enzymes, increases the net 
uptake of bilirubin by reducing efflux from the cell. 
In the endoplasmic reticulum, a specific form of uridine diphosphoglucuronate 
glucuronosyltransferase (UGT1A1) catalyzes the transfer of either one or two molecules 
of glucuronic acid to bilirubin, yielding mono and diglucuronides, collectively known as 
conjugated bilirubin (CB) (Hauser et al., 1984; Bosma et al., 1994). This conversion is 
critical since renders bilirubin water soluble and unable to diffuse across membranes. 
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Finally, the conjugated bilirubin is excreted across the bile canaliculus by the membrane 
transporter multidrug resistance protein 2 (MRP2 or ABCC2) (Kamisako et al., 1999) in 
the intestinal lumen (Figure 2). Bilirubin passes through the small intestine without 
significant absorption. In the colon, the glucuronide residues are released by bacterial 
hydrolases, and bilirubin degraded to a large family of reduction- oxidation products, 
collectively known as urobilinoids, which are mostly excreted by faeces. The conversion 
of bilirubin conjugates to urobilinoids is an important natural detoxification mechanism 
because it blocks the intestinal absorption of bilirubin known as enterohepatic circulation 
(Poland and Odell, 1971; Lester and Schmid, 1963). Only a small proportion of 
unconjugated bilirubin is reabsorbed by the intestine, returned to the liver and secreted 
again to the bile. 
 
 
Figure 2: Hepatic metabolism of bilirubin. (1) bilirubin is transported bound to albumin. (2) Bilirubin is dissociated from 
albumin and enters hepatocytes by facilitated diffusion. (3) Binding to glutathione-S-transferases (GSts). (4) Bilirubin is 
converted to mono- and diglucuronide by the action of UGT1A1. (5) Bilirubin glucuronides are actively transported into bile 
by ATP dependent pump ABCC2 (MRP2). (Adapted from Roy Chowdhury et al., 2001). 
 
1.1.2 Bilirubin Characteristics 
Unconjugated bilirubin is a nearly symmetrical tetrapyrrole, consisting of two rigid, 
planar dipyrrole units, joined by a methylene (-CH2-) bridge at carbon 10. The structure 
thus resembles a two bladed propellor, in which the blades could theoretically be joined 
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4 
 
at different angles and each blade could rotate its bond to the methylene bridge, reviewed 
by Ostrow (Ostrow et al., 1994). In the preferred “ridge-tile” conformation, the two 
dipyrrinones are synperiplanar as in a partially opened book, and the angle (ϴ) between 
the two planes is about 95°. 
The rigid biplanar structure of bilirubin IXα, the most naturally occurring isomer 
(Figure 3), with its internal hydrogen bonds, was first demonstrated in the crystalline 
state by X-ray diffraction (Bonnett et al., 1978), is also the preferred conformation in 
solution of UCB in water, alcohols, and chloroform. 
 
 
Figure 3: The structure of bilirubin IXα-Z,Z, diacid (H2B), which consist of two slightly asymmetrical, rigid, planar 
dipyrrinone chromophores, connected by a central methylene bridge. (Adapted from Pu et al. Tetrahedron 47: 6163-6170). 
 
At physiological pH values in plasma (7.40), tissues (7.60) and bile (6.00 to 8.00) 
there is a significant ionization of the –COOH groups of the natural IXα isomer of UCB 
(Hahm et al., 1992), so in addition to the diacid (H2B), a proportion of UCB is present as 
monoanion (HB
-
) and dianion (B
2-
) as shown in Figure 4. The pK’a values of the –COOH 
groups on the two carboxymethyl (propionyl) side chains determine the proportion of the 
free UCB species at any given pH. At pH 7.40 (e.g. plasma) the preponderant form of 
INTRODUCTION 
5 
 
UCB is H2B (83 %), HB
-
 represent the 15 % and B
2-
 less than 1.5 % of total UCB (Hahm 
et al., 1992). 
 
1.1.3 The free bilirubin theory 
In blood, the total amount of bilirubin is formed by three principal forms: albumin-
bound unconjugated bilirubin (UCB-A), conjugated bilirubin (CB) and unbound 
unconjugated bilirubin (free bilirubin, Bf). The Bf represents less than 0.1 % of the 
pigment found in blood (Ahlfors, 2001; Weisiger et al., 2001). 
 
 
Figure 4: Proportions of unbound species of unconjugated bilirubin at pH 6.00 to 8.00, derived from partitions of UCB from 
chloroform into buffered NaCl at ionic strength 0.15. (Adapted from Hahm et al., J. Lipid Res. 33: 1123-1137). 
 
In 1959 Odell (Odell, 1959) proposed for the first time that only non-albumin-bound 
bilirubin (free bilirubin, Bf) is available for transport into brain and recommended that 
the measurement of Bf level would be better than total bilirubin in predicting risk for 
kernicterus. However it took additional 15 years before Wennberg reports a successful 
method to assess Bf in serum (Jacobsen and Wennberg, 1974). This proposal has been 
successfully popularized as the “free bilirubin theory” (Wennberg, 2000; Calligaris et al., 
2007). 
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The proportion of free UCB depends on the presence of albumin and its binding 
affinity constants. If the quantity of bilirubin does not exceed the albumin binding 
capacity (bilirubin/ albumin ratio is lower than 1) the maximal amount of UCB circulates 
in blood bound to human serum albumin (HSA), being 435 μM (25 mg/dL) the highest 
quantity of UCB transported bound to HSA (Brito, 2006). On the contrary, if the 
bilirubin/ albumin ratio is more than 1, the albumin binding capacity for UCB is 
exceeded and the amount of Bf sharply rises (Diamond and Schmid, 1966). In these 
conditions, the Bf, which is mainly in the non-ionised (diacid, H2B) form at physiological 
pH, can passively diffuse across membranes and enters into tissues (Gourley, 1997; 
Zucker et al., 1999). 
 
1.2 Disorders of bilirubin metabolism 
Hepatic transport of bilirubin, as described previously, involves four distinct but 
related stages: uptake from circulation, intracellular binding or storage, conjugation and 
biliary excretion. In pathological situations, abnormalities in the bilirubin metabolic 
pathway may cause hyperbilirubinemia. In severe inheritable disorders, the transfer of 
bilirubin from blood to bile is disrupted at a specific stage, depending on which stage 
abnormality occurs, hyperbilirubinemia of unconjugated or conjugated type will be 
produced (Strassburg, 2010; Roy-Chowdhury, 2001). 
 
1.2.1 Disorders leading to unconjugated hyperbilirubinemia 
 
Neonatal hyperbilirubinemia 
During the foetal development, the maternal placenta is responsible for cleaning the 
bilirubin from the foetal circulation. Upon birth, this placental protection is suddenly lost, 
and bilirubin clearance is totally accomplished by the infants. Just at that moment a sharp 
increase in the production of unconjugated bilirubin occurs. 
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7 
 
The daily production of bilirubin is of 6-8 mg/kg in healthy term infants and 3-4 
mg/kg in adults. This increase is principally due to: the shorter red blood cells life span of 
newborns (70-90 vs. 120 days in adults), the immaturity of the hepatic bilirubin 
conjugation (Rubaltelli, 1993). In addition, the absence of the intestinal flora in the 
newborn infant lead to more non-metabolized UCB available for intestinal absorption, 
increasing the enterohepatic circulation of UCB (Vitek et al., 2000). Therefore, a 
significant retention of UCB occurs in almost all healthy term neonates (Gourley, 1997; 
Blanckaert et al., 1976; Dennery et al., 2001). 
Almost 60% of neonates become clinically jaundiced in the first week of life, with 
elevated serum bilirubin levels (UCB between 5 mg/dL and 7 mg/dL) (Maisels, 2000), 
that returned to normal over the next 1-2 weeks without treatment (Ostrow et al., 2003a). 
This condition is known as “physiologic jaundice”. 
However, neonatal physiological jaundice may be aggravated by various combinations 
of: (1) augmented bilirubin production (e.g. due to haemolysis) (Stevenson et al., 2001); 
(2) increased enterohepatic circulation (Gartner, 2001); and (3) hereditary defects, 
prematurity, or abnormally delayed maturation of the hepatic conjugation mechanism for 
UCB (Ostrow et al., 2003a; Kaplan et al., 1997). The high serum UCB levels observed in 
this case, favours the entry of UCB into the central nervous system, and may cause 
neurotoxicity, bilirubin encephalopathy and kernicterus. 
 
Bilirubin encephalopathy 
Bilirubin encephalopathy or BIND (Bilirubin Induced Neuronal Dysfunction) is 
usually a reversible condition, particularly at the early stages, characterized by hypotonia/ 
hypertonia, lethargy, poor suckling, and abnormal brainstem auditory evoke potentials 
(BSAEP) (Ostrow, 1987; Connolly and Volpe, 1990). This condition is caused by 
moderated levels of hyperbilirubinemia (200- 300 μM; 11.7 mg/dL) (Ostrow, 1987). 
Phototherapy is the preferred treatment in such cases, converts UCB to photo isomers that 
can be excreted in bile and urine without conjugation. Cases not responding to 
phototherapy underwent exchange transfusion (Hansen et al., 2009). 
INTRODUCTION 
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Kernicterus 
The term “Kernicterus” originally referred to a pathologic diagnosis typified by 
staining of the brainstem nuclei and cerebellum with bilirubin in infants or children who 
had manifested signs of acute or chronic bilirubin encephalopathy. The serum UCB 
levels may exceed the 20 mg/dL, resulting in permanent neurological sequelae and even 
death. The symptoms are: cerebral palsy and spasticity, deafness or diminished hearing, 
impairment of upward gaze, and dental emamel dysplasia. Corresponding to lesions in 
the globus pallidus, subthalamic nucleus, auditory and oculomotor brainstem nuclei, 
respectively, with the cerebellum and hippocampus also affected (Kaplan and 
Hammerman, 2005b; Ostrow, 1987; Shapiro, 2010). 
 
Crigler - Najjar syndrome 
The Crigler – Najjar syndrome (CNS) was first described in 1952 (Crigler and 
NAJJAR, 1952), is a rare genetic disorder (one in 1x10
6
 newborns) characterized by 
severe non-haemolytic unconjugated hyperbilirubinemia. This syndrome is caused by a 
deficiency of the UGT1A1. Different mutations in the UGT gene have been identified. 
Patients affected by this disease have been classified in two groups: Crigler – Najjar type 
I (CNIS) and type II (CNIIS) depending on the remaining UGT1A1 activity and the 
response to phenobarbital administration. 
Crigler – Najjar type I is the most severe type, characterized by the absence of 
UGT1A1 and no response to phenobarbital treatment. Serum bilirubin levels typically 
range from 15 to over 50 mg/dL and, if untreated with exchange transfusions and daily 
phototherapy, may result in kernicterus with permanent neurological damage or death. 
Currently, liver transplantation is the only definitive treatment (Van Der Veere et al., 
1996; Sampietro and Iolascon, 1999). Mutations in type I syndrome are mainly missense 
mutations, nonsense mutations, mutations leading to a premature stop codon, frame shift 
and splice sites, all leading to no enzyme-protein, truncated enzyme or inactive full length 
enzyme (Kaplan and Hammerman, 2005a). 
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In Crigler – Najjar type II the UGT1A1 activity is decreased and treatment with 
phenobarbital reduce the serum bilirubin levels by stimulation of the UGT1A1 gene 
(Arias et al., 1968), rendering this condition less severe. Due to the presence of UGT1A1 
residual activity the bilirubin levels found in serum are lower (10- 20 mg/dL) than those 
found in CNIS (Sampietro and Iolascon, 1999). The missense mutations found in this 
cases result in partial enzyme activity (Kaplan and Hammerman, 2005a). 
 
Gilbert syndrome 
This syndrome is characterized by mild hyperbilirubinemia without evidence of 
hemolysis or liver disease. It is a common, benign condition and 3-10 % of general 
population is estimated to have it. Mild icterus is the only abnormal physical finding and 
even this is lacking in the majority of cases. The serum bilirubin concentration in this 
patients are usually less than 5 mg/dL (Sampietro and Iolascon, 1999). The most common 
genetic polymorphism encountered in patients of Gilbert’s syndrome is that of an 
additional TA insertion in the TATAA box of the UGT1A1 promoter, although not all 
individuals homozygous for the promoter mutation manifest clinical signs of this 
condition (Bosma et al., 1995; Strassburg, 2010). 
 
1.2.2 Disorders leading to conjugated hyperbilirubinemia 
 
Dubin - Johnson syndrome 
Dubin- Johnson syndrome is a benign rare disease characterized by a chronic, 
predominantly conjugated non-haemolytic hyperbilirubinemia and black pigmentation of 
the liver, without other abnormalities of clinic-chemical test for liver dysfunction 
(DUBIN, 1958; Shani et al., 1970). Hyperbilirubinemia reaches 50-100 μM/L but levels 
exceeding 400 μM are possible (Strassburg, 2010). This syndrome is due to a nonsense 
mutation of the coding region of the gene for MRP2 (ABCC2), the canalicular membrane 
transporter that normally extrudes a vast number of metabolites into bile, including 
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conjugated bilirubin. Bilirubin glucuronides reflux into blood creating a typical pattern of 
conjugated hyperbilirubinemia, and are excrete by the kidneys causing bilirubinuria. 
 
Rotor syndrome 
The Rotor syndrome is a benign disease and has a strikingly similar presentation to 
Dubin- Johnson syndrome. It is characterized by accumulation of conjugated bilirubin in 
presence of normal liver function test, but without the liver pigmentation. It is suggest 
that the underlying mechanism impaired is the hepatocellular storage of conjugated 
bilirubin, which results in hyperbilirubinemia by leakage into the plasma (Berthelot and 
Dhumeaux, 1978). The mode of inheritance is autosomal recessive but the association to 
a specific gene has not been reported (Strassburg, 2010). 
 
1.3 Bilirubin neurotoxicity 
The reoccurrence of bilirubin encephalopathy and its occasional appearance at plasma 
bilirubin levels below therapeutic guidelines (Maisels and Newman, 1998) have revived 
the interest in understanding the molecular mechanism of UCB induced neurotoxicity. 
Even though it is well established that only the unbound fraction of UCB in plasma 
(free bilirubin, Bf) is responsible of bilirubin neurotoxicity (Calligaris et al., 2007; 
Wennberg, 2000; Ahlfors and Wennberg, 2004), neither the underlying cellular and 
molecular mechanism nor the selective pattern of bilirubin damage in the brain are well 
understood. Since there is not a great agreement regarding which might act as a 
mechanistic focal point and which be the most clinically relevant. Furthermore, most 
published in vitro studies of neurotoxicity of UCB have been performed at total UCB 
levels vastly higher than those seen in jaundice neonates or hyperbilirubinemic Gunn rats 
(Ostrow et al., 2003b). 
Bilirubin neurotoxicity is selective, certain areas of the brain and certain cell types 
within these regions are more affected than others. The classic anatomic changes 
observed in brain of children with extreme bilirubin encephalopathy or kernicterus 
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consist of yellow discoloration and degenerative changes more marked in the basal 
ganglia, hippocampus, cerebellum and cochlear nuclei. This pattern of involvement is 
remarkably similar across term, preterm, previously well, or septic neonates, the rarely 
reported adult with kernicterus, or those seen in experimental animal models as the Gunn 
rat with bilirubin encephalopathy induced by displacing agents (Aono et al., 1989; Daood 
and Watchko, 2006; Ostrow, 1987). The reason for the selective affinity of bilirubin for 
those brain sites is uncertain; some possible explanations are: differences in lipid 
composition in these areas (Cashore, 1990); accumulation and clearance of UCB (Gazzin 
et al., 2012); in the metabolic rate and/ or requirements of these tissues as compared with 
the rest of the brain (Ostrow, 1987; McCandless and Abel, 1980). 
It has been shown that among the cells forming these tissues (neurons, astrocytes, 
oligodendrocytes, and microglia), nerve cells (particularly granular cells and Purkinje 
cells) are the main target for UCB cytotoxicity. In fact, several effects of UCB toxicity to 
neurons have been reported either in brain sections (Danbolt et al., 1993; Hansen et al., 
1988b; Sawasaki et al., 1976), cultured cell lines (Ngai et al., 2000; Notter and Kendig, 
1986), or isolated nerve terminals (Hansen et al., 1988a; Vazquez et al., 1988). Although 
neurons (Notter and Kendig, 1986) have been suggested as more susceptible than 
astrocytes, more recent reports describe compromised astrocyte function following UCB 
interaction (Silva et al., 1999; Silva et al., 2002; Amit and Brenner, 1993). 
It has been suggested that the neuronal injury caused by bilirubin is initiated at level of 
plasmatic, mitochondrial (Schutta et al., 1970; Rodrigues et al., 2000), and/ or 
endoplasmic (Calligaris et al., 2009) compartment with consequent alterations of 
membrane permeability and function (Rodrigues et al., 2002b; Brito et al., 2004), 
possibly triggering excitotoxicity (Grojean et al., 2000; McDonald et al., 1998), 
mitochondrial energy failure, and increased intracellular calcium levels (Brito et al., 
2004), that finally lead to activation of apoptotic or necrotic pathways (Watchko, 2006; 
Silva et al., 2001; Falcao et al., 2007; Vaz et al., 2010). 
Additionally, it has been shown that bilirubin impairs DNA and protein synthesis 
(Yamada et al., 1977; Schiff et al., 1985; Kashiwamata et al., 1980), cell proliferation 
(Sukhotnik et al., 2009), receptor functionality (Hoffman et al., 1996), and 
neurotransmitter uptake and release (Ochoa et al., 1993; Silva et al., 1999). 
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More recently, it has been shown in vivo that high concentrations of bilirubin in Gunn 
rats blood clearly suppress the development of vascular neointimal hyperplasia after 
ballon injury (Ollinger et al., 2005; Ollinger et al., 2007b) and that treatment of tumors 
with bilirubin inhibits its growth (Ollinger et al., 2007a; Rao et al., 2006). It was also 
demonstrated in vitro that treatment of primary cultures and tumoral cell lines with 
bilirubin/ biliverdin caused the arrest of the cell cycle progression in the late G1 phase, by 
a decrease of Cyclin D, E, A as well as Cdk2 protein amount in treated cells (Rao et al., 
2006; Ollinger et al., 2005; Ollinger et al., 2007b; Ollinger et al., 2007a). New evidences 
also indicates that cell cycle regulating proteins are involved in apoptotic process in post-
mitotic neurons (Herrup and Busser, 1995; Wen et al., 2005). 
 
1.4 The Gunn rat 
In 1934 a new mutant strain of Wistar rats, with non-hemolytic unconjugated 
hyperbilirubinemia, was discovered by Gunn (Gunn, 1938) (Figure 5). From that moment 
on, the Gunn rat has been used as animal model of Crigler- Najjar type I syndrome and 
neonatal jaundice, as like in humans they manifest a congenital inherited deficiency of 
hepatic UDP-glucuronosyl-transferase, and similar neuropathological lesions (Schutta 
and Johnson, 1967; Chowdhury et al., 1993). 
In Gunn rat, the UGT1A1 deficiency is due to the deletion of a single base pairs 
(guanosine) in the common region exon 4, which results in a stop codon that remove the 
115C- terminal amino acids of the protein. This truncated protein is unstable and rapidly 
degraded (Chowdhury et al., 1991; Chowdhury et al., 1993; Iyanagi et al., 1989). 
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Figure 5: Photograph of Gunn rats at 9-days after birth (P9), the yellow discoloration of the skin is clearly visible in jj 
hyperbilirubinemic animals while JJ normal rats appear white. 
 
In hyperbilirubinemic (jj) rat, the level of bilirubin in serum show a pronounced 
increase (13.60- 14.60 mg/dL) from birth to age P17, declining to a persistent 
hyperbilirubinemia (4.90 mg/dL) throughout their life, as shown in Figure 6 (Gazzin et al., 
2011; Zarattini et al., 2011). 
 
 
Figure 6: Plasma bilirubin in jj and JJ Gunn rat. (Adapted from Gazzin et al., 2011. PLoS ONE 6:1; and Zarattini et al., 
Experimental models). 
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Morphologically, the brain is affected almost selectively in jj rat. The brain 
hippocampus, virtually all basal ganglia, and most brain stem nuclei are damaged in 
affected rats, with a distribution similar to that seen in humans (Schutta and Johnson, 
1967). In contrast to human kernicterus, cerebellar hypoplasia is a prominent feature of 
bilirubin damage in Gunn rat (Schutta and Johnson, 1967; Sawasaki et al., 1976; Conlee 
and Shapiro, 1997). Also a significant reduction on the cerebellar weight was found in jj 
rats respect to the normal’s heterozygous (Jj) and homozygous (JJ) littermates (Gazzin et 
al., 2011; Zarattini et al., 2011) (Figure 7). Cerebellar damage by bilirubin is most severe 
in the anterior lobe (Sawasaki et al., 1976) where most serious and early changes are 
observed in Purkinje cells (Schutta and Johnson, 1967; Takagishi and Yamamura, 1989). 
There is a decreased area of the molecular layer and diminished cell number in the 
granule layer, while an hypertrophy of astrocytes is found (Chowdhury et al., 1993; 
Mikoshiba et al., 1980; O'Callaghan and Miller, 1985; Sawasaki et al., 1976). 
 
 
Figure 7: Cerebellar weight in jj and JJ Gunn rat. A. Representative photograph of JJ and jj Gunn brain, where the cerebellar 
hypoplasia is observable. B. The cerebellar growth expressed as g/ animal. Statistical significance ** p <.0.01, *** p < 0.001. 
(Adapted from Gazzin et al., 2011. PLoS ONE 6:1). 
 
It has been suggested a developmental dependence of cerebellar hypoplasia by 
bilirubin in Gunn rat (Sawasaki et al., 1976; Conlee and Shapiro, 1997). It is known that 
the rat cerebellum develops by post-natal neurogenesis (Altman and Das, 1966), and that 
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cerebellar hypoplasia in jj rat begins largely after 8 post-natal days (Conlee and Shapiro, 
1997), consistent with the critical period for bilirubin- induced cerebellar hypoplasia 
identified at 6-10 days after birth (Keino and Kashiwamata, 1989; Sawasaki et al., 1976; 
Takagishi and Yamamura, 1987; Rice and Barone S Jr, 2000). 
 
1.5 The cerebellum 
The central nervous system consists of the brain and spinal cord, while the peripheral 
system consists of all the neural (nerve) tracts that lie outside these central tissues and 
connect the rest of the body. The brain weights about 1500 g and constitutes about 2 % of 
total body weight. It consists of three major divisions: 1) the massive paired hemispheres 
of the cerebrum; 2) the brainstem, consisting of the thalamus, hypothalamus, epithalamus, 
subthalamus, midbrain, pons, and medulla oblongata, and 3) the cerebellum (Figure 8). 
Due to the complexity of the whole brain structure that define each region, we only focus 
our attention on the anatomical and functional description of the area considered as target 
for our study, the cerebellum. 
 
 
Figure 8: Sagital diagram of the rat brain. (Adapted from The Gene Expression Nervous System Atlas –GENSAT- Project, 
NINDS Contracts N01NS02331 & HHSN271200723701C to The Rockefeller University, New York, NY). 
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The cerebellum functions as a kind of computer, providing a quick and clear response 
to sensory signals. It plays no role in sensory perception, but it exerts profound influences 
upon equilibrium, muscle tone, and the coordination of voluntary motor function 
(HERNDON, 1964; ITO, 2006; Nieuwenhuys et al., 2008). 
The gross anatomy of the cerebellum is characterized by transverse fissures of 
different depths, which subdivide the cerebellum into lobes, lobules and folia (leaflets). 
The cerebellum consists of a large mass of white matter, the medulla of the cerebellum, 
over which is disposed a greatly folded layer of gray matter, the cerebellar cortex. The 
cortex has a very complex structure, being made up of many different kinds of neurons, 
but it appears to be composed of only three layers. A monolayer formed by the perikarya 
of the large Purkinje cells separates the superficial, cell-poor molecular layer from the 
deep layer of granule cells (Nieuwenhuys et al., 2008; Craigie, 1925). The molecular 
layer consists primarily of the stellate and basket cells as well as dendrites of the Purkinje 
cells and the parallel fibres (axons of the granule cells), while the granular layer contains 
the densely packed somata of granule cells together with the somata of Golgi cells. 
 
 
Figure 9: Perpendicular organization of the dendritic trees of the Purkinje cells and axons of the granule cells, also known as 
the parallel fibres. (Adapted from Nieuwenhuys R., Voogd J., Van Huijizen C.-2008. The human central Nervous System. 4th 
Edition). 
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Purkinje cells are large neurons with very elaborated and characteristic dendritic 
arbors which extend into the molecular layer and are oriented perpendicularly to parallel 
fibres (Figure 9). Purkinje cells axons extend out through to granular layer to the white 
matter and then project to targets in the cerebellar and vestibular nuclei. They are of 
particular functional interest since their axons provide the sole output from the cortex. 
These large cells are inhibitory and use gamma- aminobutiric acid (GABA) as their 
neurotransmitter (ITO et al., 1964). 
Granule cells are very small and the most prevalent neuronal subclass within the 
cerebellum. Granule cells emit four or five thin dendrites that terminate in digit-like 
protrusions, the axons ascend toward the molecular layer, where they split into two 
branches that run parallel to the transverse fissure and, therefore called parallel fibres. 
Parallel fibres may reach a length of 10 mm or more and terminate with excitatory 
(glutamatergic) synapses on the spiny branchlets of Purkinje cell dendrites and on the 
dendrites of cortical interneurons they meet in the way (Nieuwenhuys et al., 2008). They 
play an essential role in the coordination of the afferent input to and motor output from 
the cerebellum through their excitatory connections with Purkinje neurons (ITO, 2006). 
Moreover, cerebellar granule cells are powerful inducers for Purkinje cells differentiation. 
Astrocytes are a specific class of glial cells, they are estimated to comprise only the 20 % 
of cells in the cerebellum, while neurons represent the 80 % (Herculano-Houzel and Lent, 
2005). As the name suggests, are process-bearing stellate or star-shaped cells and have 
been classified into protoplasmic and fibrous type based on their morphology and 
distribution in the central nervous system. In most instances, protoplasmic astrocytes 
predominate in gray matter and fibrous astrocytes are most common in white matter. 
Astrocytes are multifunctional cells that are indispensable for neuronal survival and 
function. They provide the migratory scaffold for neurons; represent the major source of 
extracellular matrix proteins, adhesion molecules and glycogen. They also contributed to 
the formation and preservation of a secure blood-brain barrier. Astrocytes control ionic 
and osmotic homeostasis, remove neurotransmitters from the synaptic cleft, and produced 
a variety of trophic factors. They have important roles in development and plasticity of 
the central nervous system by modifying the growth of axons and dendrites, and 
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regulating synapse formation. In addition they contribute to the control of the immune 
responses (Montgomery, 1994). 
The rat cerebellum development initiates on E12 (E12, embryonic day 12) and 
continues beyond the 16-19 post-natal days (P16-P19) (Rice and Barone S Jr, 2000). 
Cerebellar development is dominated by the interplay between two germinal epithelia – 
the external granular layer, which produces the granule cells, and the ventricular zone of 
the fourth ventricle, which produces the Purkinje cells. During post-natal development of 
rat cerebellum, in the external granule layer two distinct zones can be clearly identified, 
the proliferative and the pre-migratory zone. The post-mitotic cells of the external 
granular layer migrate to their final destination in the internal cell layer (Altman, 1972). 
The proper development of the nervous system requires apoptosis, which systematically 
removes a lot of cells not only in the proliferative zones, but also among the post-mitotic 
cells (Blaschke et al., 1998; Blaschke et al., 1996). Apoptosis is a physiological feature of 
central nervous system development, and the period of neuronal apoptosis is between P0 
and P14 in rat (Cheng et al., 2011), during which animals are more susceptible to suffer 
brain damage (Rice and Barone S Jr, 2000). 
 
1.6 The cell cycle 
The cell cycle is a ubiquitous, complex process involved in the growth and 
proliferation of cells, organism development, regulation of DNA damage repair, tissue 
hyperplasia as a response to injury, and diseases such as cancer. The cell cycle involves 
numerous regulatory proteins that direct the cell through a specific sequence of events 
culminating in mitosis and the production of two daughter cells. Central to this process 
are the cyclin-dependent kinases (Cdks) and the cyclin proteins that regulate the cell’s 
progression through the stages of the cell cycle referred to as G1, S, G2, and M phases 
(Figure 10). The cell cycle can be morphologically subdivided into interphase and stages 
of M (mitotic) phase, which include prophase, methaphase, anaphase, and telophase. 
Interphase encompasses G1, S, and G2 (Schafer, 1998). 
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The G1 and G2 phases of the cell cycle represented the “gaps” in the cell cycle that 
occur between DNA synthesis and mitosis, during which mRNAs and proteins 
accumulate continuously. In the first gap, G1 phase, the cell is preparing for DNA 
synthesis. S phase cells are synthesizing DNA and therefore have aneuploid DNA content 
between 2N and 4N. The G2 phase is the second gap, during which the cell prepares for 
mitosis or M phase. In the G0 phase (quiescence) cells are not actively cycling. 
 
1.6.1 Cell cycle regulation 
Cyclin- dependent kinases (Cdks) are the key regulator proteins which allow the 
transition from one cell cycle phase to another, these serine/ threonine protein kinases are 
activated at specific points during the cell cycle (Collins and Garrett, 2005; Vermeulen et 
al., 2003). Positive regulation of Cdk activity occurs through association with cyclin and 
by phosphorylation of the T-loop threonine by Cdk- activating kinase (Park and Lee, 
2003). Cyclins are produced at each of these phases and form a complex with their Cdk 
partners. The levels of activating cyclins in different stages of the cell cycle differ, 
whereas the Cdk protein levels remain stable (Vermeulen et al., 2003). During the G0 to S 
phase transition, cyclins D1, D2, D3 and C get activated. Cyclins D1, D2, and D3 bind to 
Cdk4 and Cdk6 where as cyclin C binds to Cdk8. Cyclins D1, D2, D3 are the first cyclins 
to be induced as the G0 cells are stimulated to enter the cell cycle. The progression 
through G1 is mediated by cyclin D isoforms and Cdk2, -4, and -6. In G1 an important 
target of the Cdks is the retinoblastoma protein (pRb), and the G1 cyclin- cdk complexes 
phosphorylate pRb on multiples residues (Kato et al., 1993). Once the cyclin- cdk 
phosphorylates pRb, pRb releases the transcription factor E2F, freeing it to participate in 
transcription of proteins necessary for the progression of the cell cycle (Schafer, 1998). 
Cyclin E is associated during G1 to S phase transition and activates Cdk2. Cyclin A gets 
activated during the S phase transition and binds to Cdk1 and Cdk2. B type cyclins are 
present during G2 exit and mitosis phase and are associated with Cdk1 (Figure 10). 
Cdks are also regulated by inhibitory phosphorylation and by inhibitory molecules. 
The inhibitory phosphorylation is mediated by the kinase Wee1 and MYT1. Two classes 
of Cdk inhibitors also regulates Cdks function, the INK4 group such as p16
INK4a
 or 
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p15
INK4b
 and CIP/KIP class such as p21
waf1
 or p27
kip1
 (Park and Lee, 2003; Maddika et al., 
2007). 
 
 
Figure 10: Cell cycle regulation. (Adapted from Herrup and Yang. 2007. Nat. Rev. Neurosci., 8(5); 368-378) 
 
1.6.2 Cell cycle and apoptosis 
Each phase of the cell cycle contains checkpoints that allow the arrest of the cell cycle 
progression and activation of repair mechanisms (Johnson and Walker, 1999). After 
passing these checkpoints cells are irreversible committed to the next phase. DNA 
damage and/ or malfunction of other critical organelles or structure (e.g. faulty mitotic 
spindle) can activate the cell cycle arrest and even the apoptotic cascade, leading to cell 
death (Rowinsky, 2005). The induction of programmed cell death occurs via two major 
pathways: the death receptor-dependent (extrinsic) pathway through TNF- family ligands, 
or via the mitochondrial (intrinsic) pathway induced by different factors such as UV 
radiation, chemotherapeutics, free radicals or DNA damage (Los et al., 1995; Maddika et 
al., 2007). The induction of apoptosis leads to cell blebbing, exposure of 
phosphatidylserine at the cell surface, reduction of cell size, shrinkage of the cell core, 
DNA condensation and the formation of apoptotic bodies (Darzynkiewicz et al., 1997). 
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The cell cycle regulators have been shown to be involved also in the induction of 
apoptosis. Cyclin A1, E, D1, and p53, E2F and Rb have a dual role in the regulation of 
the cell cycle and apoptosis as reviewed by Maddika (Maddika et al., 2007). 
There are two mammalian A-type cyclins, namely Cyclin A1 and A2. Cyclin A1 is 
limited to male germ cells and brain (Sweeney et al., 1996; Yang et al., 1997). Cyclin A1 
null mice show cell cycle arrest and apoptosis of spermatocytes (Salazar et al., 2005). 
Apparently, Bax expression is elevated in Cyclin A1 null mice’s spermatocytes as 
compared to the normal mice leading to their apoptotic demise. This clearly shows that 
cyclin A1 plays a vital role in the regulation of apoptotic process by inhibiting the 
expression of Bax gene. Molecular mechanisms revealed that apoptotic cell death is due 
to the cell cycle arrest in G2/M transition phase by downregulation of Cyclin A and 
subsequent upregulation of proapoptotic Bcl2 family proteins (Palozza et al., 2002). 
Recent investigations revealed that Cyclin E is responsible for induction of apoptosis 
in hematopoietic cells (Mazumder et al., 2002). Cyclin E usually exists as a 50-kDa 
protein (Full Length, FL). During apoptosis it is cleaved into a 18-kDa fragment (p18-
Cyclin E) by caspases and it can no longer bind to the Cdks. Overexpression of Bcl2 
protein downregulated the apoptotic process and at the same time reduced the expression 
of p18-Cyclin E (Mazumder et al., 2002). Unexpected evidence indicates that p18-Cyclin 
E interacts with the Ku-70, a critical component in the non-homologous end-joining 
repair. It is speculated that interaction of cyclin E might inhibit the activity of Ku-70 and 
hence augments the apoptotic process by inhibiting the DNA repair mechanism 
(Mazumder et al., 2004). 
In neuronal cells the cell cycle is linked to neurogenesis (Ohnuma and Harris, 2003), 
and also serve to diverse post-mitotic functions that span various developmental stages of 
a neuron, including neuronal migration, axonal elongation, axon pruning, dendrite 
morphogenesis, and synaptic maturation and plasticity as review by Frank and Tsai 
(Frank and Tsai, 2009; Becker and Bonni, 2005). There are also growing evidences that 
cell cycle- related molecules appear to play key role in neuron death during normal 
development as well as in disease and trauma. Once neuronal cells became a mature 
neuron (post-mitotic), the mature neuron will keep this status until the organism dies. 
Increasing evidence over the last decade supports the notion that neuronal cell cycle re-
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entry result in post-mitotic death (Becker and Bonni, 2004; Becker and Bonni, 2005; 
Chen and Wang, 2008; Greene et al., 2007; Herrup and Yang, 2007). 
 
1.7 Cryopreservation 
Cryopreservation allows the long term storage of cells, which has a number of 
applications. Clinically, cells may be stored by a patient for their own use at a later date 
or to facilitate donation to other patients. Having stored the cells, they can be distributed, 
making it easier to co-ordinate patient care, and avoiding the need to synchronise donor 
and recipient. The ability to store cells reduces wastage of cells if they cannot be used 
fresh, and allows the pooling of cells from two o more donors where cells from a single 
donor are insufficient for a clinical effect. Cell storage is also of great value in scientific 
research; allowing archiving of material, repeated experiments from the same tissue 
source and, by allowing the stored of samples, facilitates research collaboration. 
There are three methods for cells and tissue storage: a- culture at 37°C, is time 
consuming and primary cultures of cells and tissue can be maintained for a limited time; 
b- cold storage at 4°C has been reported to allow good survival of primary tissue up to a 
maximum of 8 days, and c- cryopreservation, (-150 to -196°C) allow virtually indefinite 
storage. In this work, we focus our attention only in cryopreservation. 
 
Conventional cryopreservation (slow freezing) has been successful with embryos of 
different species and immortalized cell lines. This technique based on achieving a cooling 
rate that allows the formation of extracellular ice and a slow cell dehydration has been 
successful with cell suspensions, but lethal to tissue and organs, for which the 
maintenance of an extracellular architecture is indispensable (Taylor et al., 2004). Some 
of the cell damage caused by conventional cryopreservation are summarized in Table 1 
(Yannas, 1968). Slow-cooling is achieved using a controlled rate freezing machine, but 
simpler devices can be used. 
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Affected cellular system Damage 
Whole cell 
Formation of intra and extracellular ice, apoptosis, toxicity, imbalance of cellular 
calcium levels, generation of free radicals, metabolic failure  
Membranes Breaking, loss of substrates, fusion, phase change 
Chromosome Loss/ gain 
DNA Apoptosis, fusion 
Cytoskeleton Breakdown of microtubules 
Proteins, enzymes Dehydration, loss of function 
Ultrastructure Alterations in mitochondria, vesicles 
Table 1: Damages caused by conventional cryopreservation. 
 
During storage at temperatures below -130°C all biological events cease hence no 
deterioration of the sample occurs. What is potentially damaging to cells is cooling to, 
and warming from, the storage temperature. When cells are cooled to just below 0°C, 
there will be no ice formation due to the presence of solutes. As cells are cooled further 
( -5 to – 15°C) ice formation begins to occur. The ice is formed preferentially in the 
extracellular medium, this creates an osmotic gradient across the cell membrane, resulting 
in water being drawn out of the cells, the cell will shrink and cell contents will become 
concentrated. The increase in intracellular solutes can reach toxic levels, being the major 
factor causing cellular injury with slow-cooling rates (Mazur, 1970). 
 
In order to cryopreserve cells successfully, they must be exposed to cryoprotectans. 
The cryoprotective agents are classified in two types: membrane permeating (glycerol, 
ethylene glycol, DMSO, propanediol) and no-permeating (sucrose, ficoll, proteins) 
(Fuller, 2004). Those belonging to the first group act through any of the following 
mechanism: decreasing the solution freezing point, preventing cell damage by increasing 
the electrolyte concentration and interacting with the membranes modifications during 
cryopreservation process. For classic cryopreservation procedures, the concentration of 
permeating cryoprotectans is limited to 1-1.5 M, and so the potential toxicity is low. The 
no-permeating cryoprotectans exert its beneficial effect by increasing the concentration of 
extracellular solutes, generating an osmotic gradient across the cell membrane. Once the 
sample is warmed, the cryoprotectans must be removed from cells. Stepwise removal of 
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cryoprotectans can be used to alleviate osmotic stress, as can the presence of non-
permeating solutes, to help prevent excessive water entry as the concentration of 
permeating cryoprotectans is decreased. 
Cryopreservation has been used routinely in prolonged storage of many mammalian 
tissues such as blood, bone marrow cells, spermatozoa and embryos used clinically. The 
cryopreservation of neural cells/ tissue started to be interesting followed the successful 
transplantation of such tissues, initially for studies of brain development, formation and 
regeneration of neuronal connections, and later for clinical transplantation (Olanow et al., 
1996). The first report of viable frozen-thawed nerve tissue was that of Luyet and 
Gonzales (LUYET and GONZALES, 1953). Several studies have been performed to 
achieve cryopreservation of nervous tissue, cells (Ichikawa et al., 2007), primary neural 
tissue, neural progenitors cells and neural stem cells have been subjected to freezing, as 
summarized by Paynter in 2008 (Paynter, 2008). However, for these cells types 
cryopreservation has not been applied with sufficient success to enable it to be 
incorporated into routine clinical practice. 
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2. AIMS OF THE STUDY 
 
In neonates and in Crigler-Najjar syndrome type I patients, severe unconjugated 
bilirubin (UCB) accumulation may cause brain damage and death early in life. The Gunn 
rat is the animal model to study these pathologies. The hyperbilirubinemic jj Gunn rat 
develops a marked cerebellar hypoplasia with degeneration and loss of Purkinje cells and 
granule neurons. Recently it has been shown that high levels of bilirubin cause the arrest 
of the cell cycle progression in the late G1 phase by a decrease of all Cyclins (D, E, A) as 
well as Cdk2 protein. Until now, the role of cell cycle arrest by bilirubin in cerebellar 
hypoplasia has not been investigated. 
Bilirubin neurotoxicity was shown to be selective, only certain areas of the brain and 
only certain cells types within these regions are more affected than others. Among the 
cells forming the cerebellum (neurons, astrocytes, oligodendrocytes, and microglia) nerve 
cells, particularly granular cells and Purkinje cells are the main target for UCB 
cytotoxicity. The selectivity of bilirubin to arrest the cell cycle differentially in cerebellar 
astrocytes and granule neurons has not been investigated. 
Bilirubin neurotoxicity was shown to reduce significantly the quantity of cerebellar 
granule neurons found in the granular layer. The successful transplantation of neuronal 
cells for studies of brain development, formation and regeneration of neuronal 
connections, and for clinical transplantation, lead us to hypothesize the possibility of 
transplanting cryopreserved granule neurons to the hypoplasic cerebellum of jj Gunn rat 
so as to reduce the effect of bilirubin on cerebellar granule cells. Several studies have 
been performed to achieve cryopreservation of nervous tissue and cells, but without 
sufficient success to enable it to be incorporated into routine clinical practice. 
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Based on these considerations the aims of this PhD thesis were: 
 
 the first aim was to evaluate the cell cycle progression and expression of 
the cell cycle regulators (mRNA and protein) in cerebellum of normal (JJ) 
and hyperbilirubinemic (jj) Gunn rat. 
 
 the second aim was to evaluate the cell cycle progression and expression of 
the cell cycle regulators (mRNA) in primary cultures of cerebellar 
astrocytes and granule neurons treated with high concentrations of bilirubin. 
The effect of bilirubin on the rate of apoptosis in astrocytes primary culture 
was also evaluated. 
 
 the third aim was to assess the possibility of cryopreserving cerebellar 
granule neurons by conventional cryopreservation (slow freezing) 
methodology, and to set up the conditions for its cryopreservation. So as to 
generate a cryopreserved stock of granule cells for future transplantation in 
jj Gunn rat. 
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3 MATERIALS & METHODS 
 
3.1 Materials, Chemicals and Reagents 
Dulbecco’s Modified Eagle Medium low glucose (DMEM) and Basal Medium Eagle 
with Earle’s salts, without L-glutamine (BME) were obtained from Invitrogen, Life 
Technologies Corporation, Grand Island, NY, and L-glutamine from EuroClone, Milano, 
Italy. 
Foetal Bovine Serum (FBS), gentamycin (50 mg/mL, Solution), fatty acid free bovine 
serum albumin fraction V (BSA), trypsin from bovine pancreas, trypsin inhibitor from 
glycine max (soybean), deoxyribonuclease I from bovine pancreas, poly-L-lysine 
hydrobromide molecular weight 30,000-70,000, cytosine-β-D-arabino-furanoside, 
TriReagent, Bicinchoninic Acid protein Assay kit (BCA), β-mercaptoethanol, Triton 
X100, PBS (Dulbecco’s Phosphate Buffered Saline), propidium iodide (Pi), ribonuclease 
A from bovine pancreas DNAse free, unconjugated bilirubin (UCB), 3(4,5-
dimethiltiazolil-2)-2,5 diphenil tetrazolium (MTT), dimethyl sulfoxide (DMSO), 
Coomassie blue solution, Ponceau solution and (S)-(+)-camptothecin were purchased 
from Sigma-Aldrich, St. Louis, MO, USA. 
The nylon cell strainers of 40, 70 and 100 µm were obtained from BD falcon
Tm
, BD 
Biosciences, Bedford, USA, and 6 Well cell culture cluster-Costar 3516 (6-well plate) 
was obtained from Corning Inc., Corning, NY, USA. 
iScript
TM
 cDNA Synthesis Kit, iQ
 TM
 SYBR Green Supermix and Laemmli buffer were 
purchased from Bio-Rad Laboratories, Hercules, CA, USA. Cell Lysis buffer was 
obtained from Cell Signaling Technology, Inc; Danvers, MA, USA. 
All the other reagents and chemicals were of analytical level. 
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3.2 in vivo and in vitro bilirubin effect on cell cycle 
3.2.1 Animals 
Animals of both sexes were obtained from the animal facility of the Department of 
Life Sciences of Trieste University (Trieste, Italy) and from the animal facility of the 
Faculty of Biochemical and Pharmaceutical Sciences of National University of Rosario 
(Rosario, Argentina). Animal care and procedures were conducted according to the 
guidelines approved by the Italian Law (decree 116-92), by the European Communities 
Council Directive 86-609-EEC and by the Argentinean National Council for Scientific 
Research. All efforts were made to minimize the number of animals used and their 
suffering. 
Two different rat strains were used in this Thesis. SpdBlueGUNN.j-rats and Wistar 
Han
TM
 (RccHan
TM
:WIST) rats, purchased from Harlan Illinois, were used. Both rat 
strains were grown in the local animal facility. 
For the in vivo study, hyperbilirubinemic (jj) and normobilirubinemic (JJ) Gunn rats at 
9 days after birth P9 (Post-natal age, P9), as well as, Wistar rats (P3, P9 and P60) were 
used. While for the in vitro study, only P2 and P8 Wistar rats were used. 
 
3.2.2 Rat cerebella dissection 
Animals from all post-natal ages were sacrifice by decapitation under isofluorane 
anaesthesia, their brains were rapidly excised and placed for the in vivo study in 4°C 
Krebs-Ringer buffer (NaCl 135 mM; KCl 4 mM; CaCl2 2.2 mM; MgCl2 1.2 mM; 
NaHCO3 6 mM; Hepes 10 mM; D-Glucose 5 mM, pH 7.40) and for the in vitro study at 
room temperature (RT) in DMEM or BME culture medium as described below. 
Under stereomicroscope vision the cerebella (Cll) was immediately dissected, cleaned 
from meninges and 4
th
 ventricle choroid plexus as previously described (Gazzin et al., 
2008). Particularly, in the in vivo study, the Gunn rats cerebella was longitudinally 
divided in two parts, one part for mRNA analysis and the second part for protein studies. 
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3.2.3 Primary cell cultures 
Primary astrocyte cultures 
Primary cultures of astrocytes were obtained pooling the cerebella dissected from 6 
Wistar rats pups (P2) as described previously by Booher (Booher and Sensenbrenner, 
1972) with minor modifications. 
The dissected Cll were collected in RT Dulbecco’s Modified Eagle Medium, low 
glucose (DMEM) supplemented with 10 % heat-inactived foetal bovine serum (FBS) and 
50 µg/mL gentamycin, and cut into small pieces. Immediately after that, cells were 
mechanically dissociated by forcing the tissue through a 70 µm nylon cell strainer (# 
352350, BD Biosciences) using a plunger of a 5 mL syringe in a tissue culture dish 
containing 5 mL supplemented DMEM. The filter was removed and the cell suspension 
was dissociated 20 times through a 5 mL pipette, keeping the pipette vertical with its end 
stuck to the bottom of the dish, for avoiding cells aggregates. 
The resulting cell suspension was diluted (1:4), and cells were seeded at 1.2 x 10
5
 
cells/mL in 6-well plates. The cells were incubated in culture medium containing DMEM 
(low glucose), 10 % inactive FBS and 50 µg/mL gentamycin in a culture incubator at 
37°C in an atmosphere of 95 % air/ 5 % CO2, with 90 % humidity. The culture medium 
was replaced the next day, to remove debris and twice a week thereafter. The purity of 
the astrocyte cultures was determined by immunocytochemical staining using the 
astrocyte marker glial fibrillary acidic protein (GFAP) vs. Hoechst staining of nuclei. 
Experiments were performed on cultures with age between 12 and 16 days in vitro (div) 
when they reach 90 % of confluence. Two days before the experiments the culture 
medium was changed with Neuron Medium (Basal Medium Eagle: BME, 10 % heat-
inactivated FBS, 2 mM L-glutamine, 25 mM KCl, 10 mM Hepes, 44 mM NaHCO3, 5.6 
mM D-glucose, 100 µg/ml gentamycin, pH 7.40) where experiments of astrocytes and 
granule neurons were conducted. 
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Primary cerebellar granule cultures 
Primary cultures of cerebellar granular cells (CGC) were obtained pooling the 
dissected cerebella from six P8 Wistar rats as described previously by Mitchell (Mitchell 
et al., 2007; Dutton et al., 1981) with minor modifications. 
The dissected Cll were collected at RT in BME medium with 100 µg/mL gentamycin. 
The tissue was grossly triturated in 90-mm plastic Petri dish, transferred into a sterile 50 
mL tube containing 10 mL of RT Solution 1 (0.03 % MgSO4 and 3 mg/mL BSA in Krebs 
buffer: 124 mM NaCl, 5.37 mM KCl, 1.01 mM NaH2PO4.H2O, 2.7 µM Phenol Red, 25 
mM Hepes, 14.5 mM D-glucose, pH 7.40) and centrifuged at 200 g for 1 min. After 
decanting the supernatant, the tissue pellet was resuspended in 10 mL RT Solution 2 
(0.03 % MgSO4, 3 mg/mL BSA and 0.12 mg/mL trypsin in Krebs buffer) and incubated 
at 37°C for 15 min with gentle agitation. After incubation, the trypsin was inhibited by 
the addition of 10 mL of RT Solution 4 (0.03 % MgSO4, 3 mg/mL BSA, 0.16 mg/mL 
trypsin inhibitor, 0.014 mg/mL DNase I in Krebs buffer). The suspension was divided in 
two 15 mL tubes and centrifuged at 200 g for 1 min. The supernatant was decanted, and 3 
mL of RT Solution 3 (0.07 % MgSO4, 3 mg/mL BSA, 0.52 mg/mL trypsin inhibitor, 
0.045 mg/mL DNase I in Krebs buffer) was added to each tube and the tissue pellet was 
gently triturated (~17 times) through a sterile fire-polished glass Pasteur pipette. After 
allowing standing for 10-15 min at RT the supernatants were transferred to two fresh 15 
mL conical tube, leaving ~ 500 µl of supernatant containing mostly cell clumps. More 
Solution 3 was added to the tissue pellet and gentle disruption was repeated as described 
above. The second collection of isolated cells was combined with the first, and 1.25 mL 
of Solution 3 was added to each tube. To reduce the amount of debris, and inhibit DNases, 
the isolated cells were centrifuged through RT 4 % BSA gradient-Solution 5 (0.06 % 
MgSO4, 0.001 % CaCl2, 3 mg/mL BSA in Krebs buffer). Using a 2 mL pipette 2 mL of 
the gradient solution were placed below the two supernatants, this yields a two-step 
gradient which was centrifuged at 180 g for 5 min (Cambray-Deakin, 1995). The cell 
pellet of the two tubes were put it together and resuspended in 5 mL of Neuron Medium 
(BME, 10 % heat-inactivated FBS, 2 mM L-glutamine, 25 mM KCl, 10 mM Hepes, 44 
mM NaHCO3, 100 µg/mL gentamycin, pH 7.40). 
Cells were counted using a Burker chamber, and cell viability was evaluated by trypan 
blue dye exclusion. Briefly, 10 µl of the cell suspension was diluted 1:50 in 0.4 % (w/v) 
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trypan blue solution, living and dead (blue) cells were counted, the % of viable cells was 
calculated. The cells were them plated in 5 µg /mL poly-L-lysine pre-coated 6-well plate 
at the density of 1.5 x10
6
 cells/well in Neuron Medium. After plating, the cells were 
incubated at 37°C in an atmosphere of 95 % air/ 5 % CO2, with 90 % humidity. After 24 
h the medium was renewed with the addition of cytosine-β-D-arabino-furanoside (Ara-C, 
10 µM), to prevent the growth of non-neuronal cells, and D-glucose (5.6 mM). From that 
moment on, the medium was changed twice a week. All experiments were carried out 
after 7 days in culture (7 div). 
 
UCB solutions and Bf measurements 
The free (unbound) bilirubin (Bf) concentration in each culture medium was evaluated 
using a modification of the horseradish peroxidase assay (Ahlfors, 2000) as described by 
Roca (Roca et al., 2006). 
Unconjugated bilirubin (UCB) was purified as described by Ostrow and Mukerjee 
(Ostrow and Mukerjee, 2007), divided into aliquots, and stored at -20°C until used. 
Immediately before each cell treatment, an aliquot was dissolved in DMSO (0.3 µl of 
DMSO per µg of UCB), and diluted with each culture medium containing 10 % FBS 
(25.6 µM BSA). Experiments were performed with two final UCB concentrations of 5 
and 25 µM, yielding two free unbound UCB concentrations (Bf): one corresponding to 
the physiological serum Bf and the other to the serum Bf calculated from P9 
hyperbilirubinemic (jj) Gunn rat. 
In order to standardize DMSO-related effect, control cells were incubated with 
medium containing DMSO 0.5 % (the quantity of DMSO needed to dissolve the UCB 25 
µM). To minimize photo-degradation, all the experiments with UCB were performed 
under light protection (dim lighting and vials wrapped in tin foil). 
 
MATERIALS & METHODS 
32 
 
Culture and treatment conditions 
Astrocytes and CGC primary cultures were grown for 12-16 and 7 div, respectively in 
the corresponding medium (DMEM and Neuron Medium). The cultures were monitored 
daily to check their progress. At the moment of treatment, cells were washed once with 
37°C PBS and then incubated in 4 different conditions:. 
 Cells alone: complete medium. 
 Control group: complete medium plus DMSO 0.5 %. 
 UCB 5 µM: complete medium plus 5µM UCB (yielding a physiological Bf of 
20 nM) 
 UCB 25 µM: complete medium plus 25 µM UCB (yielding a Bf of 140 nM, as 
in P9 hyperbilirubinemic Gunn rats) 
 
Cell viability after UCB treatment 
The assay used to evaluate cell viability was based on the reduction of 3(4,5-
dimethyltiazolyl-2)-2,5 diphenyl tetrazolium (MTT) to formazan crystals (Mosmann, 
1983; Denizot and Lang, 1986). 
Primary astrocyte and CGC cultures were grown on 6-well plates and treated with two 
final UCB concentrations of 5 and 25 µM for different periods of time (from 10 min up to 
24 h). Considering the possibility of performing astrocyte/ CGC co-cultures, astrocytes 
were grown in DMEM and two days before treatment the medium was changed to 
Neuron Medium without Ara-C. In this case for both astrocytes and CGC, treatment was 
made in Neuron Medium without Ara-C. 
A MTT stock solution of MTT (5 mg/mL in PBS pH 7.40) was diluted to 0.5 mg/mL 
in the corresponding treatment medium (2 mL) immediately before the treatments. The 
cells were washed once with PBS and incubated for 1 hour at 37°C. After incubation, 
MTT formazan crystals were dissolved by adding 0.5 mL DMSO with gentle shaking. 
The absorbance was measured at 570 nm in a LD 400C Luminescence Detector, 
Beckman Coulter, Milan Italy. Results were expressed as percentage of control cells, not 
exposed to UCB, which was considered as 100 % viability. 
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3.2.4 Gene expression analysis 
RNA extraction 
For the in vivo study the half part of the cerebellum of P9 JJ and jj Gunn rats dedicated 
to gene analysis, was collected directly in TriReagent solution, and total RNA was 
isolated according to the manufacture's protocol. 
For the in vitro study primary astrocyte and CGC cultures were grown on 6-well plates 
and treated for 2 and 24 hours, with 25 µM UCB. Total RNA was isolated by TriReagent 
solution according to the manufacture's suggestions. 
In both cases total RNA concentration and purity were quantified 
spectrophotometrically in a Beckman DU640. For each sample a A260/A280 ratio 
between 1.8 and 2.0 was considered as good RNA quality criteria. The RNA integrity 
was evaluated by agarose gel electrophoresis and staining with ethidium bromide, 
indicating that the RNA preparations were of high integrity. The isolated RNA was 
dissolved in RNAse free water and stored at -80°C until analysis. 
 
mRNA Quantification by Real-Time RT-PCR 
Expression analysis of house-keeping genes and the target genes were performed by 
Real Time RT-PCR technology, using specific primers (see Table 2). 
Retrotranscription of total RNA (1 μg) was performed with an iScriptTM cDNA 
Synthesis Kit according to the manufacturer’s instructions. The reaction was run in a 
thermal cycler (Gene Amp PCR System 2400, Perkin-Elmer, Boston, MA, USA) at 25°C 
for 5 min, 42°C for 45 min, and 85°C for 5 min. The final cDNA was conserved at –20°C 
until used. 
The primers for the targeted genes Cyclin D1, E1, A, A1 and Cdk2 and the four 
possible house-keeping genes (18S, Actin, hypoxanthine-guanine 
phosphoribosyltransferase: Hprt1 and glyceraldehydes 3-phosphate dehydrogenase: 
Gapdh) were designed using Beacon Designer 4.2 software (PREMIER Biosoft 
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International, Palo Alto, CA, USA). All primer pairs were synthesized by Sigma Genosys 
(Cambridgeshire, UK). Primer sequences are reported in Table 1. 
 
Gene Accession Number Forward Reverse Amplicon 
(bp) 
18S 
X01117 TAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG 150 
Actin NM_031144.2 GGTGTGATGGTGGGTATG CAATGCCGTGTTCAATGG 103 
Gapdh NM_017008.3 CTCTCTGCTCCTCCCTGTTC CACCGACCTTCACCATCTTG 87 
Hprt1 NM_012583.2 AGACTGAAGAGCTACTGTAATGAC GGCTGTACTGCTTGACCAAG 163 
Cyclin D1 NM_171992.4 AGCTGAGGCGTCCCAACC CAACCAGAATACACAAAGCCAACC 173 
Cyclin E1 NM_001100821.1 CAGTCAGCCTTGGGATGATGATTC TCCTCCAGACCTCTTCTCTATTGC 185 
Cdk2 NM_199501.1 CGGCAGGATTTTAGCAAGGTTGTG CAGGTGAAGAGGGCTTTGGGAAG 192 
Cyclin A1 NM_001011949.1 TATCTTCCTTCCTTGGTAG TAATGAATAGCCCGTAAATG 105 
Cyclin A NM_053702.3 TAGATGCTGACCCATACC TCCTGTGACTGTGTAGAG 83 
Table 2: Primers sequences designed for the mRNA quantification. 
 
The reaction was performed on 25 ng of cDNA, with the corresponding gene-specific 
sense and anti-sense primers (250 nM, except 18S and Cyclin A1 primers, were we used 
100 nM and 300 nM respectively) with 1x iQ SYBER Green Supermix (Bio-Rad 
Laboratories, Hercules, CA, USA) in a final volume of 25 µl for each gene except Cyclin 
A1, were we used 50 µl. Reactions were run on an iCycler iQ thermocycler (Bio-Rad 
Laboratories, Hercules, CA, USA). The thermal cycler conditions consisted of 3 min at 
95°C and 40 cycles each at 95°C for 20 s, 60°C for 20 s, and 72°C for 30 s. 
The PCR was performed in 96-well plates; each sample was analysis in triplicate. 
Standard curves using a “calibrator” cDNA (chosen among the cDNA samples from 
normal JJ Gunn rats) were prepared for each target and house-keeping gene. Melting 
curve analysis was performed to asses product specificity. The relative quantification was 
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made using the iCycler iQ Software, version 3.1 (Bio-Rad Laboratories, Hercules, CA, 
USA) by the Pfaffl modification of the ΔΔCT equation (CT: cycle number at which the 
fluorescence passes the threshold level of detection) (Pfaffl, 2001; Tichopad et al., 2004), 
taking into account the efficiencies of the individuals genes. The results were normalized 
to the chosen housekeeping genes and the initial amount of the template of each sample 
was determined as relative expression vs. one of the sample chosen as reference which is 
considered the 1x sample. 
 
3.2.5 Protein expression analysis 
Protein extraction 
For the in vivo study the half part of the cerebellar tissue of P9 JJ and jj Gunn rats 
dedicated to protein analysis, was homogenized in homogenization buffer (0.25 M 
Sucrose; 50 mM K2HPO4; 50 mM KH2PO4; 1 mM EDTA; 0.1 mM DTT; pH 7.40) at 
4 °C, using a Dounce-type glass homogenizer. The protein homogenate was stored at -
80°C until analysis. 
For the in vitro study primary astrocyte and CGC cultures were grown on 6-well plates 
as previously described and treated for 2 and 24 hours, with 25 µM UCB. Total cells 
extracts were obtained by lysing cells in ice-cold Cell Lysis buffer (Cell Signaling 
Technology) for 5 min on ice. The cell lysate was centrifuged at 14.000 g for 10 min at 
4°C, and the supernatant was collected and stored at -80°C until analysis. 
In both cases total protein content was determined by the Bicinchoninic Acid Protein 
Assay (BCA) kit (Smith et al., 1985), following the manufacturer’s protocol (Procedure # 
TPRO 562). 
 
Western blot 
Proteins homogenates from Cll of P9 JJ and jj Gunn rats (20, 25, 30 or 50 µg, 
depending on the analysed protein) were denatured with 10 % β-mercaptoethanol in 
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Laemmli loading buffer (62.5 mM Tris-HCl, pH 6.80; 25 % glycerol, 2 % SDS, 0.01 % 
bromophenol blue) by 10 min boiling in water bath and separated by SDS-PAGE on 10 
or 12 % polyacrylamide gels. Molecular weight standards (10-205 kDa, #SM1811 
Fermentas) were used as marker proteins. After that proteins were electro-transferred 
with a wet blotting system (BioRad Laboratories, Hercules, CA, USA) at 100 V for 1 h 
onto PVDF membrane (0.2 µm; Whatman Schleicher & Schuell, Dassel, Germany) in 
transfer buffer (25 mM Tris-Base; 192 M glycine, 0.1 % SDS; 20 % methanol). 
Completeness of transfer was assessed by lack of Coomassie blue coloration of the gels 
after blotting and Ponceau staining of PVDF membranes. 
Membranes were saturated for 2 h in blocking solution 4 % non fat milk or 4 % BSA 
in T-TBS (20 mM Tris-Base; 500 mM NaCl, pH 7.40, 0.2 % Tween 20) and incubated 
overnight at 4°C with antibodies anti Cyclin D1, Cylin E, Cyclin A, Cdk2, PARP-1, α-
Tubulin and Actin (Table 3) in the same buffer. After washing, membranes were 
incubated for 1h at RT with peroxidase-conjugated anti-rabbit or anti-mouse secondary 
antibodies (P0448, 0.04 µg/ml, and P0260, 0.26 µg/ml, Dako, Glostrup, Denmark). 
Protein bands were detected by peroxidase reaction according to the manufacturer’s 
protocol using a chemiluminescence procedure (Millipore, Billeria, MA, USA) and 
visualized on X-ray films (BioMax Light, Kodak Rochester, NY, USA). 
 
The intensity of the autoradiography bands was estimated by densitometry scanning 
using NIH Image software (Scion Corporation, Frederick, MD, USA). The protein 
relative expression was finally obtained as previously described (Gazzin et al., 2008; 
Gazzin et al., 2011). Briefly a standard curve was generated by serial dilution of a 
reference sample on each gel and a non-linear regression analysis of the densitometry 
analysis was performed by CurveExpert 1.38 Software (Starkville, MS, USA) to obtain 
the protein expression that was later normalized for the concomitant actin signal (Figure 
11). 
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Protein 
Blocking 
Solution 
Concentration 
(µg/ml) 
Antibody Manufacturer 
Cyclin D1 4% BSA 13.5 [DCS-6] ab10540 Abcam, Cambridge, UK 
Cyclin E 4% BSA 2.0 [E-4] SC-25303 
Santa Cruz Biotechnology, Santa Cruz, CA, 
USA 
Cyclin E 4% non fat milk 2.0 [M-20] SC-481 
Santa Cruz Biotechnology, Santa Cruz, CA, 
USA 
Cyclin A 4% BSA 0.5 [H-432] SC-751 
Santa Cruz Biotechnology, Santa Cruz, CA, 
USA 
Cdk2 4% non fat milk 0.03 [M2] SC-163 
Santa Cruz Biotechnology, Santa Cruz, CA, 
USA 
Parp-1 5% non fat milk 0.034 #9542 
Cell Signaling Technology, Inc; Danvers, 
MA, USA 
α-Tubulin 4 % non fat milk 0.04 [DM1A]: SC-32293 
Santa Cruz Biotechnology, Santa Cruz, CA, 
USA 
Actin 4% non fat milk 0.1 A2066 Sigma, St. Louis, MO, USA 
Table 3: Antibodies and conditions used for Western blot 
 
The analysis of p18-Cyclin E protein expression was performed using the M-20 
antibody that recognised the C-terminal portion of Cyclin E. The low protein expression 
of the 18 kDa fragment of Cyclin E (p18-Cyclin E) forced us to load up to 50 µg of 
protein for the Western blot analysis, precluding the formation of a well defined standard 
curve. Therefore, the results of the p18-Cyclin E protein expression were obtained only 
by normalization with the actin signal. 
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Figure 11: Representative western blot for Cyclin D1 quantification. A. Photograph of a representative Western blot showing 
the standard curve and the evaluated samples. B. Representative non-linear regression curve obtained from the standard curve 
by Curve Expert 1.38 Software. 
 
3.2.6 Cell cycle analysis by FACS 
Cell dispersal and fixation 
For the in vivo study freshly dissected cerebellum from P9 JJ and jj Gunn rats, and P3, 
P9 and P60 Wistar rats were collected directly in cold PBS/EDTA (0.1 % w/v EDTA, 
PBS pH 7.40) and dispersed as previously described with minor modifications (Heinlein 
et al., 2010; Heinlein and Speidel, 2011). Briefly, small pieces (about 3 x 3 x 3 mm) of 
the tissue were mechanically dispersed, sequentially using 100 µm and 40 µm nylon cell 
strainers (# 352360 and # 352340 respectively, BD Bioscience). The tissue was first 
pressed through the 100 µm mesh using a plunger of 5 mL syringe in a tissue culture dish 
containing PBS/EDTA. The mesh was then rinsed several times with 4°C cold 
A. 
B. 
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PBS/EDTA. The resulting cell suspension (5 mL) was filtered through 40 µm cell strainer 
and the total volume was adjusted with PBS/EDTA to 15 mL per sample. After 
centrifugation (310 g; 4°C; 6 min) and removal of the supernatant, the cell pellet was 
suspended in 0.5 mL 4°C cold PBS. 
For the in vitro study primary astrocyte and CGC cultures were grown on 6-well 
plates as previously described and treated for 2 and 24 hours, with 25 µM UCB. Cells 
were harvested with trypsin into a 15 mL tube, keeping media as this helps to inactivate 
trypsin. After centrifugation (200 g, 6 min, RT) and removal of the supernatant, the cell 
pellet was suspended in 0.5 mL 4°C cold PBS. 
In both cases the cells were immediately fixed by adding 5 mL of cold (-20°C) 80 % 
ethanol drop-wise under constant gentle vortexing. Samples were incubated for 30 min 
on ice and subsequently stored at -20°C until staining. 
 
Staining and analysis 
Staining was performed after removal of the fixed cell suspensions from -20°C storage 
and stabilization at RT for ≈ 10 min. After centrifugation (310 g; RT; 6 min) pellets were 
resuspended in 5 mL PBS/EDTA (RT), incubated for 5 min at RT and pelleted again (310 
g; RT; 6 min). Cell sediments were resuspended in 1mL of staining solution PBS with 
0.1 % v/v Triton X-100, 20 µg/ml propidium iodide (Pi), and 0.2 mg/ml DNAse free 
RNase A; that warrants saturation of all DNA with Pi. Samples were incubated for 30 
min at RT and subjected to FACS (fluorescence activated cell sorter) analysis. 
Cells were analyzed using the cytometer BD FACSCalibur
TM
 and CellQuest software 
(BD Biosciences, San Jose, CA). Briefly Pi fluorescence excited with a 488 nm argon ion 
laser was detected in the FL2 channel (> 600 nm band-pass filter). Doublets and higher 
aggregates were excluded by making a gate in the pulse-width versus pulse-area 
histogram. Data were collected for 10,000 events per sample. 
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3.2.7 in vitro analysis of apoptosis/ necrosis by FACS 
Primary astrocyte cell cultures were grown on 6-well plates and treated for 2 and 24 
hours, with 25 µM UCB and with (S)-(+)-camptothecin 6 µM for 4 h, as positive control. 
The rate of apoptosis/ necrosis was evaluated with the Annexin V-FITC Kit (Bender 
MedSystems GmbH, Vienna, Austria) according to the manufacture's protocol. Briefly, 
cells were harvested with trypsin into a 15 mL tube, keeping media as this helps to 
inactivate trypsin. After centrifugation (200 g, 5 min, 4°C) and removal of the 
supernatant, cells were washed in PBS and centrifuged again (200 g, 5 min, 4°C). The 
cell pellet was resuspended in ice-cold Annexin V-binding buffer (10 mM Hepes, 140 
mM NaCl, 2.5 mM CaCl2, pH 7.40), Annexin V-FITC and Pi were added and incubated 
for 10 min at RT. 
Samples were analyzed by generating a dot plot showing Annexin V-FITC (FL1) 
versus Pi (FL2), and defining quadrants that divide cell populations according to Annexin 
V and Pi positivity. Single-stained cells were included in the experiments to set up 
compensation and quadrant markers, i.e. cells stained only with Annexin V-FITC and 
cells stained only with Pi. The FL1 (520 nm) and FL2 (610 nm) channels were used to 
detect Annexin V-FITC staining and Pi uptake, respectively, on a cytometer BD 
FACSCalibur
TM
 (BD Biosciences, San Jose, CA) equipped with a argon-ion laser at 488 
nm. Data were collected for 10,000 cells and analyzed using CellQuest software from BD 
Biosciences (San Jose, CA). 
 
3.3 Neural cells cryopreservation 
3.3.1 Equipment for sample freezing 
The following equipment was used to perform the cryopreservation of neuronal cells 
by slow freezing methodology, as its allow the execution of cooling ramps at different 
speeds. Consist of a 500 mL Dewar, containing liquid nitrogen (LN2); a 400 mL glass 
Beacker with methanol, an electronic Thermometer (Tes 1303, Taiwan) and K-type 
thermocouple, different thermic transfer units (in this case copper bars), a magnetic 
agitator, a stirring bar Kartell Cat. 788 (7 mm x 35 mm) and a computer, that collected all 
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the data measured by the thermometer and K-type thermocouple. Briefly, the Dewar 
containing the liquid nitrogen was connected through the transfer unit to the Beacker, 
generating a cold methanol bath, where the cryovials (Nunc, Cryotube
TM
 Vials) 
containing the sample and a control cryovial holding the K-type thermocouple were 
immersed for its slow freezing (Figure 12). 
 
 
 
Figure 12: Equipment used for slow freezing cryopreservation. A. Description of the components. B. The equipment ready 
to be use. 
 
A. 
B. 
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3.3.2 Primary cerebellar granule cells cultures 
The cerebellar granular cells suspension was obtained as described previously in 
section 3.2.3. The cell suspension was divided in two, one part of the cells were plated in 
5 µg /mL poly-L-lysine pre-coated 6-well plate at the density of 1.5 x10
6
 cells/well in 
Neuron Medium, and the other one was cryopreserved as described below. After 24 h of 
plating the cryopreserved CGC, the medium was renewed with the addition of D-glucose 
(5.6 mM), but without Ara-C. The next time the medium was changed Ara-C (10 µM) 
was added to prevent the growth of non-neuronal cells. From that moment on, the 
medium was changed twice a week. The culture was maintained for 7 div, as a control for 
a proper isolation process. 
 
3.3.3 Cryopreservation 
Freezing conditions 
In the first set of experiments the isolated CGC (Figure 13 A), whose viability were 
always greater than 95 %, were cryopreserved with different ratios of DMSO as 
cryoprotective agent (9, 10, 15, 16.6, 23.1 and 28.6 %) in order to choose the best 
proportion of DMSO to produce the best viability after cryopreservation. Briefly, the cell 
suspension was centrifuged at 70 g for 5 min, and the cell pellet was resuspended in 1 mL 
of Neuron Medium with the corresponding % of DMSO. After a incubation of 15 min in 
ice, the cells were centrifuged (70 g for 5 min) and the cell pellet was finally resuspended 
in 100 µl of Neuron Medium with DMSO and put it in a cryovial and plunging in LN2. 
In the second set of experiments the isolated CGC (Figure 13 B), whose viability were 
always greater than 95 %, were cryopreserved in Neuron Medium with 10 % DMSO at 
different freezing rates using the slow freezing methodology. The different freezing rates 
were achieved using three different cooper transfer units (5/8, 3/8 and 1/4 inch) an 
agitation rate of the methanol bath of 780 rpm. The temperature of the sample and the 
methanol bath was measured with the thermometer and K-type thermocouple every 
minute, the data was directly collected in a computer, and a graph temperature vs. time 
was generated. The freezing rate was calculated using the linear part of the curve. Briefly, 
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the isolated cells were centrifuged at 70 g for 5 min, the supernatant was discarded and 
the pellet was resuspended in 3 mL of Neuron medium with 10 % DMSO, and the final 
suspension was divided in three aliquots of 1 mL each in cryovials. Samples were left for 
10 min in a 10°C bath. Finally the cryovials were submerged in the methanol bath and the 
temperature was decreased with different freezing rates to -40°C, at that point cryovials 
were deposited in the Liquid Nitrogen tank (-196°C) until use. 
 
 
Figure 13: Representative diagram of freezing and rewarming conditions used in the two set of experimentes. A. First set of 
experiments. B. Second set of experiments. 
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Rewarming conditions 
In the set of experiments designed to testing the different proportions of the 
cryoprotective agent DMSO (9, 10, 15, 16.6, 23.1 and 28.6 %), the cryopreserved 
samples were quickly rewarmed in a 37°C bath. The rewarmed cell suspension was 
centrifuged 70 g for 2 min. After removing the supernatant, the cells were resuspended in 
1 mL of Neuron medium, incubated for 15 min on ice and plated as described above. For 
the samples that were cryopreserved with the highest quantity of DMSO (15, 16.6, 23.1 
and 28.6 %), the DMSO was removed by dilution. For example, the cells cryopreserved 
with 28.6 % DMSO after the rewarming they were centrifuged, the pellet was 
resuspended in medium with 14.5 % DMSO and incubated for 15 min in ice. After that, 
another centrifugation was perform, the pellet was then resuspended in medium with 7.8 % 
DMSO and incubated for 15 min in ice. Finally, cells were centrifuged, the pellet 
resuspended in Neuron Medium without DMSO and plated as described above (Figure 13 
A). 
In the second set of experiments the three aliquots were thawed under different bath 
temperature (36 and 39°C) and with RT air using the same equipment. The rewarming 
rate was evaluated as described for freezing rate. The cells were thawed, the medium was 
diluted with the addition of 1 mL of fresh Neuron medium and centrifuged 70 g for 4 min. 
The cell pellet was resuspended in fresh Neuron medium and plated as described above 
(Figure 13 B). 
In both cases the effectiveness of the cryopreservation and rewarming process were 
evaluated from the study of the viability post-rewarming and the capacity for survival in 
culture by x days in vitro. The cultures were monitored daily to check their progress. 
 
3.3.4 Viability after rewarming 
Immediately after rewarming cells were counted using a Neubauer chamber, and cell 
viability was evaluated by trypan blue dye exclusion. Briefly, 10 µl of the cell suspension 
was diluted 1:50 in 0.4 % (w/v) trypan blue solution, living and dead (blue) cells were 
counted, the % of viable cells was calculated. 
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3.4 Statistical analysis 
Unpaired t-test, for the in vivo study, and one-way ANOVA with Dunnett or Tukey-Kramer 
post test, for the in vitro study, were performed using InStat 3.06 (GraphPad Software, San Diego, 
CA, USA). Differences were considered statistically significant at a p value lower than 0.05. All 
results were expressed as mean ± S.D. 
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4 RESULTS 
 
4.1 in vivo bilirubin effect on cell cycle 
4.1.1 Gene expression 
Selection of reference genes 
In order to select the best reference genes for studying the gene expression of the cell 
cycle regulators in the cerebellum of hyperbilirubinemic and normal Gunn rat, the most 
commonly used reference genes β-Actin, Gapdh, Hprt1 and 18S were measured by real-
time RT-PCR and the variation in the cycle threshold (Ct) was assessed in both genotypes. 
The expression stability (M), the average pair wise variation of a particular gene 
compared with all other tested reference genes, was evaluated using geNorm and Norm-
Finder software (Vandesompele et al., 2002; Andersen et al., 2004). Lower M values 
indicate higher expression stability, with 0.5 being a suggested cut-off for stable genes 
(Hellemans et al., 2007) (Table 4). Since the Ct for 18S and Actin was significantly 
different (p < 0.05) between the two genotypes (JJ vs. jj), and that the analysis of the 
expression stability indicated that the best combination of reference genes was Gapdh 
and Hprt1, these two genes were selected as reference genes. 
 
Reference Gene/ Genotype 
Cycle Threshold (Ct) geNorm 
(M) 
Norm-Finder 
(M) JJ jj 
18S 14.7 ± 1.2 13.5 ± 1.1* 0.132 1.779 
Actin 15.7 ± 0.5 15.2 ± 0.3* 0.032 0.278 
Gapdh 16.9 ± 0.4 16.8 ± 0.4 0.024 0.036 
Hprt1 20.9 ± 0.4 20.8 ± 0.4 0.028 0.040 
Table 4: Real-Time RT-PCR of reference genes in normal (JJ) and Hyperbilirubinemic (jj) Gunn rat (N = 9). The Ct values 
are Mean ± S.D. Statistical significance * p < 0.05. M: stability value. 
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mRNA expression of cell cycle regulators 
The mRNA levels of selected cyclins (D1, E1, A, A1) and cyclin dependent kinases 2 
(Cdk2; constitutively expressed) in the cerebellum were quantified by Real Time RT-PCR. 
We selected these cyclins and Cdk2 based on previous observations indicating that bilirubin 
affects cell cycle (Ollinger et al., 2005; Ollinger et al., 2007b). Hyperbilirubinemic animals (jj) 
were compared to age matched (P9) normobilirubinemic controls (JJ) (Figure 14). 
In cerebella of hyperbilirubinemic jj rats, the mRNA expression of Cyclin D1 (20 %) 
and Cyclin A (15 %) showed a modest downward trend, whereas Cyclin A1 (germinal, which 
expression was lower  than Cyclin A, as demonstrated by a Ct of 30 vs. 20); Cdk2 expression 
was comparable to non-jaundiced JJ controls. On the contrary, the Cyclin E1 mRNA level 
was increased by 45 % (p ≤ 0.01) in hyperbilirubinemic jj pups (Figure 14). 
 
 
Figure 14: mRNA expression of Cyclin D1, E1, A, A1 and Cdk2 in cerebellum of P9 JJ and jj Gunn rats (N = 9).  Normal 
homozygous JJ and  Hyperbilirubinemic homozygous jj Gunn rat. Results were normalized to the two housekeeping genes, 
Hprt1 and Gapdh. The values are expressed as mean ± SD. Statistical significance ** p < 0.01. 
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4.1.2 Protein expression 
Protein expression of cell cycle regulators 
The protein levels of the cell cycle regulators, Cyclin D1, E, A, A1 and Cdk2 were 
evaluated by SDS-PAGE Western blot analysis. 
As shown in Figure 15 A, the antibodies used recognized band(s) at the expected 
molecular weight(s) (36 kDa for D1 and 33 kDa for Cdk2, respectively). In addition to the 
expected Cyclin E bands at 50 KDa (full length, FL), the E-4 antibody recognized also the 
cleaved forms of Cyclin E ranging from 49 to 34 KDa (low molecular weight forms, LMW); 
(Keyomarsi and Pardee, 1993; Harwell et al., 2000; Porter et al., 2001). The M-20 antibody 
against Cyclin E recognized also the 18 kDa fragment of Cyclin E (p18-Cyclin E). The anti-
Cyclin A H-432 antibody recognized the two types of Cyclin A proteins expressed (A and A1) 
(Yang et al., 1997) and its corresponding variants in rat tissues (Cyclin A1: 47.7 KDa, Cyclin 
A: 43.8 KDa and Cyclin A: 29.6 KDa). 
Similar to mRNA results, a significant decrease (each p < 0.05) in protein levels of 
Cyclin D1 (15 %), and total, as well as “43.8” and “29.6” Cyclin A variants (each about 20 %) 
was observed in hyperbilirubinemic vs. control rats (Figure 14 B). Differently from mRNA 
results, the protein levels of Cyclin A1and Cdk2 were decreased by about 30 % (p < 0.01) and 
25 % (p < 0.001), respectively (Figure 15 B) in hyperbilirubinemic animals. 
The level of the total Cyclin E (FL plus LMW) was increased about 19 % (p < 0.05) in 
jj animals, in agreement with the increase in mRNA levels. The raised level of Cyclin E was 
due entirely to the increased amounts of the LMW cleaved forms of Cyclin E; while the 
amount of the FL form (50 kDa) was unchanged (Figure 15 B). Furthermore, the protein 
levels of p18-Cyclin E were increased about 67 % (p < <0.05) in jj rats (Figure 15 B). 
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Figure 15: A. Representative Western blot and B. Protein relative expression of Cyclin D1, Cyclin E, p18-Cyclin E, Cyclin 
A, A1 and Cdk2 in cerebellum of P9 JJ and jj Gunn rats (N = 9). FL: full length Cyclin E (50 kDa), LWM: low molecular 
weight Cyclin E forms (49-34 kDa), Total: FL plus LMW Cyclin E forms.  Normal homozygous JJ and  
Hyperbilirubinemic homozygous jj Gunn rat. The values are expressed as mean ± SD. Statistical significance * p < 0.05, ** p 
<.0.01, *** p < 0.001.  
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Parp-1 cleavage analysis 
In order to analyse the presence of an apoptotic processes due to the high levels of 
bilirubin present in jj Gunn rat, we evaluated the protein levels of Parp-1 (116 kDa) 
and its cleaved form (cleaved Parp-1, cParp-1, 89 kDa) by SDS-PAGE Western blot 
analysis. As shown in Figure 16 A, cParp-1 was present both in control (JJ) and 
jaundiced (jj) animals. However (Figure 16 B), the level of Parp-1 and cParp-1 was 
significantly increased in hyperbilirubinemic jj animals by 38 % and 54 % 
respectively (each p < 0.01). 
 
 
Figure 16: A. Representative Western blot and B. Protein relative expression of PARP-1 and cPARP-1 (cleaved PARP-1) in 
cerebellum of P9 JJ and jj Gunn rats (N = 9).  Normal homozygous JJ and  Hyperbilirubinemic homozygous jj Gunn rat. 
The values are expressed as mean ± SD. Statistical significance ** p < 0.01. 
 
4.1.3 Cell cycle analysis by FACS 
Cell cycle progression during development 
In order to evaluate the cell cycle progression during the post-natal development of 
cerebella in healthy animals, the cerebella of P3 (N = 6), P9 (N = 4) and P60 (N = 4) 
Wistar rats were analysed by FACS. As shown in Figure 17, a slightly increase in the 
proportion of cells in G0/G1 (from 68 % to73 %) and G2/M (from 5 % to 7 %, p< 0.01 
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and p < 0.05) phase were observed in P9 as compared to either P3 and P60 rats. At the 
same time, in P9 animals the proportion of cells in S phase was reduced from 27 % to 20 % 
(p < 0.05) respect P3 pups. The proportion of cells in G0/G1, S and G2/M phases were 
almost identical between P3 and P60 rats. 
 
 
Figure 17: Cell cycle progression in cerebella of P3, P9 and P60 Wistar rats.  P3,  P9 and  P60 Wistar rat. The values 
are expressed as mean ± SD. Statistical significance * p < 0.05, ** p < 0.01. 
 
Bilirubin effect on cell cycle progression 
To assess the effect of hyperbilirubinemia on the cell cycle progression in cerebella, 
we evaluated the cell cycle profile in P9 normal JJ (N = 7) and hyperbilirubinemic jj (N = 
9) Gunn rats by FACS. As shown in Figure 18, in hyperbilirubinemic jj animals the 
proportion of cells in G0/G1 phase increased from 66 % to 72 % (p < 0.01), while cells in 
S phase decreased from 28 % to 22 % (p < 0.05). The percentage of cells in the latest cell 
cycle phase (G2/M) was identical in both genotypes (6 %). 
Moreover, thanks to light-scattering properties of a cell, the correlated measurements 
of forward-scattered light (FCS, proportional to cell-surface area or size) and side-
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scattered light (SSC, proportional to cell granularity or internal complexity) allowed us to 
differentiate two major subpopulations in the cell suspension obtained from JJ and jj 
Gunn rat cerebella. The first population (Subpopulation A) was characterized by smaller 
size and less granularity, while in the second population the size and granularity was 
higher (Subpopulation B) No difference was observed in the cell cycle profile of 
Subpopulation A of JJ and jj rats. On the contrary, an increase of cells in G0/G1 phase in 
jj vs. normal rats (from 57 % to 72 %, p < 0.01) was observed in Subpopulation B, 
meanwhile the proportion of cells in S (from 33 % to 22 %) and G2/M (from 10 % to 5 %) 
phases was significantly decrease in jj animals (Figure 19). 
 
 
Figure 18: Cell Cycle progression in cerebella of P9 JJ and jj Gunn rats.  Normal homozygous JJ and  
Hyperbilirubinemic homozygous jj Gunn rat. (N = 7 for JJ and N = 9 for jj). The values are expressed as mean ± SD. 
Statistical significance * p < 0.05, ** p < 0.01. 
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Figure 19: Evaluation of the cell cycle profile in the two major subpopulations observed in JJ and jj Gunn rats. A. Forward-
scattered light (FCS) vs. side-scattered light (SSC) Dot Plots. B. Cell cycle profile in Subpopulation A and B from Gunn rat 
cerebella. (N = 7 for JJ and N = 9 for jj). The values are expressed as mean. Statistical significance * p < 0.05, ** p < 0.01. 
 
4.2 in vitro bilirubin effect on cell cycle 
4.2.1 Bf and UCB solutions 
The free (unbound) plasma bilirubin concentration (Bf) was determined in each 
culture medium (DMEM and Neuron Medium, Figure 20). Solutions with different molar 
ratio UCB/ BSA (25.6 µM, contained in FBS) were generated by addition of purified 
unconjugated bilirubin to the cultures mediums (DMEM low glucose plus 10 % FBS and 
Neuron Medium low glucose plus 10 % FBS) in order to obtain solutions with variable 
doses of Bf to treat the cells. 
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Figure 20: Relationship of Bf to UCB in two albumin-containing cultures mediums.  DMEM low glucose with 10% FBS 
(25.6 µM BSA) and  Neuron Medium with 10% FBS (25.6 µM BSA). 
 
The two final UCB concentrations of 5 and 25 µM used to treat cells in each culture 
medium, yielded different free unbound UCB concentration (Bf), being respectively: 
 DMEM low glucose, 10 % FBS: 27 and 175 nM 
 Neuron Medium, low glucose, 10 % FBS: 15 and 126 nM 
 
 
4.2.2 Cell viability after UCB treatment 
To verify the effect of UCB on the two primary cell cultures, cells were treated with 
the same Bf reported above for 10, 30 min, 1, 2, 4, 8 and 24 hours. 
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Primary astrocytes culture 
 
 
Figure 21: Representative photograph of astrocyte primary culture at 14 div. Image from a Nikon eclipse Ts100 phase 
contrast light microscope. 
 
Astrocyte primary cultures were grown for about 14 div in completed DMEM (Figure 
21), and treated as described above. Cell viability was unchanged when cells were treated 
with a physiological Bf of 27 nM (UCB 5 µM) in completed DMEM medium for the 
different periods of time tested. On the contrary, when the cells were treated with a Bf of 
175 nM, UCB decreased astrocyte viability in a time-dependent manner, significant only 
after 4 hours of treatment (Figure 22 A). 
Since the Bf in the two culture mediums for each final UCB concentration were 
different, and considering the possibility of performing astrocyte/CGC co-cultures, we 
studied also the viability of astrocyte after the treatment with UCB in Neuron Medium as 
described in materials and methods. As shown in Figure 22 B, treatment in Neuron 
Medium with the lower Bf (15 nM/ UCB 5 µM) did not cause any change in viability. On 
the other hand treatment with a Bf of 126 nM (UCB 25 μM) produced a decrease in cell 
viability in a time-dependent manner, being statistically significant only after 8 hours of 
treatment. 
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The viability was not affected by the change in the treatment culture medium (DMEM 
vs. Neuron Medium), in any UCB concentration and time. Neither was affected by the 
only addition of 0.5 % DMSO (bilirubin vehicle) to the culture medium, in any time (data 
not shown). 
 
 
Figure 22: Effect of UCB on astrocytes viability- MTT time course. A. Astrocytes treated in DMEM medium with different 
doses of UCB (Bf 27 and 175 nM) for different periods of time. B. Astrocytes treated in Neuron Medium with different doses 
of UCB (Bf 15 and 126 nM) for different periods of time. Control cells were grown in its corresponding medium with 0.5 % 
DMSO for each time. Results are expressed as mean percentage values (%) ± SD of at least three independent experiments 
performed in duplicate. Statistical significance * p < 0.05, ** p < 0.01.  
A. 
B. 
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Primary cerebellar granule culture 
Cerebellar granule cells were grown for 7 div in Neuron Medium. Neurite outgrowth 
begins within hours after plating primary CGC, and mature cultures showed a dense 
network of processes which can be characterized as axons and dendrites (Burgoyne and 
Cambray-Deakin, 1988). Furthermore, CGC in culture form functional synapses (Van 
Vliet et al., 1989). As shown in Figure 23 CGC can readily be indentified in cultures by 
their small round cell bodies of 8 μm diameter and the presence of one or two neuritis. As 
previously described (Balazs et al., 1988), at this time CGC are fully developed and 
acquire the morphological, biochemical, and electrophysiological characteristics of 
mature neurons, including the synthesis and release of glutamate. Primary cerebellar 
granule cells cultures obtained using the protocol described in materials and methods 
provides a homogeneous populations of granule neurons (they represent the 90-95 % of 
the cells present in culture), with a dense network of axons and dendrites. Other cells 
which can be found in minor quantities within the cultures are astrocytes and fibroblast, 
these last cells functioning as scaffold necessary to support granule cell growth and 
development. 
 
 
Figure 23: Representative photograph of cerebellar granule cells primary culture at 7 div. Images from a Nikon eclipse 
Ts100 phase contrast light microscope. A. 10X and B. 20X. Healthy neurons organized into clumps interconnected by thick 
bundles of fibbers. 
 
A. B. 
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The CGC viability was unchanged when cells were treated with a physiological Bf of 
15 nM in Neuron Medium for different periods of time. However, when the cells were 
treated with a Bf of 126 nM (UCB 25 μM), UCB decreased CGC viability in a time-
dependent manner, being statistically significant after 10 minutes of treatment. At two 
hours of treatment the viability, reached the lowest level (~ 56) (Figure 24). The viability 
was not affected by the only addition of 0.5 % DMSO (bilirubin vehicle) to the culture 
medium, in any time (data not shown). 
 
 
Figure 24: Effect of UCB on cerebellar granule viability- MTT time course. Cerebellar granule cells treated in Neuron 
Medium with different doses of UCB (Bf 15 and 126 nM) for different periods of time. Control cells were grown in its 
corresponding medium with 0.5 % DMSO for each time. Results are expressed as mean percentage values (%) ± SD of at 
least three independent experiments performed in duplicate. Statistical significance * p < 0.05, ** p < 0.01. 
 
4.2.3 Gene expression analysis 
We investigated by Real Time RT-PCR, whether or not a toxic concentration of UCB 
(Bf 126 nM) modifies the gene expression of the cell cycle regulators. Based on the 
above described results, the intention of treating the two cells types with the same Bf, 
more importantly, considering the possibility of performing co-culture, both astrocytes 
and CGC primary cultures were treated in Neuron Medium with a Bf of 126 nM for 2 and 
24 hours. 
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Primary astrocytes culture 
Astrocytes primary cultures were first grown in completed DMEM medium and 2 days 
before treatment the medium was changed by Neuron Medium, where treatment was 
performed. As shown in Figure 25 A, at 2 hours of treatment the expression of Cyclin D1 
and Cyclin A1 were only slightly affected by UCB treatment, while the expression of 
Cyclin E, A and Cdk2 was not modified as compared to cells treated 0.5 % DMSO. No 
differences in gene expression were found between cells (kept in Neuron Medium) and 
controls (cells treated with 0.5 % DMSO) 
After 24 hours of treatment (Figure 25 B), a slight down-regulation on the expression 
of Cyclin E, Cdk2 and Cyclin A was observed, whereas the mRNA levels of Cyclin D1 
and A1 were increased. The last results are controversial because treatment with 0.5 % 
DMSO seems to affect by itself the expression of Cyclin D1 and A1 respect to cells that 
were only kept in Neuron Medium. On the contrary no differences were found for Cyclin 
E, Cdk2 and Cyclin A gene expression. 
 
Primary cerebellar granule culture 
Cerebellar granule neurons were grown in Neuron Medium for 7 div, and treated for 2 
and 24 hours with a Bf of 126 nM. As shown in Figure 26 A, the expression of Cyclin D1 
and Cdk2 was not affected at 2 hours of treatment, while the expression of Cyclin A and 
Cyclin E was slightly up-regulated, respect to control group. After 24 hours of treatment 
(Figure 26 B), a slight down-regulation on the expression of Cyclin D1 was observed 
respect to controls. Whereas, mRNA levels of Cyclin A were slightly increased, and 
mRNA levels of Cyclin E and Cdk2 were unchanged. It has to be taken in consideration 
that Cyclin D1 and A expression was affected by 2 and 24 hours treatment with 0.5 % 
DMSO respect to cells that were only kept in Neuron Medium. Cyclin A1 mRNA 
expression was not detectable. 
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Figure 25: Effect of UCB treatment on gene expression of cell cycle regulators. A. Astrocytes treated for 2 hours or B. for 24 
hours with a Bf of 126 nM. Cells corresponded to cells with only Neuron Medium; control cells were treated in Neuron 
Medium with 0.5 % DMSO. Results are expressed as mean ± SD of at least three independent experiments performed in 
duplicate. Statistical significance * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Figure 26:  Effect of UCB treatment on gene expression of cell cycle regulators. A. Cerebellar granule neurons  treated for 2 
hours and B. for 24 hours with a Bf of 126 nM. Cells corresponded to cells with only Neuron Medium; Control cells were 
treated with 0.5 % DMSO. Results are expressed as mean ± SD of at least three independent experiments performed in 
duplicate. Statistical significance * p < 0.05, ** p < 0.01. 
 
4.2.4 Cell cycle analysis 
Primary astrocytes culture 
To assess the specific effect of toxic levels of bilirubin (Bf 126 nM) on cell cycle 
progression in astrocytes, the cell cycle profile was evaluated on cells treated for 2 and 24 
hours using flow cytometry (FACS). Withdrawal of FBS from the culture medium for 24 
hours was used as positive control for cell cycle arrest; five independent experiments 
performed in duplicate were made. The astrocyte cell cycle profile was unaffected by a 
126 nM Bf in the two treatment times studied (Figure 27). 
  
A. 
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Figure 27: Cell cycle progression in astrocytes primary cultures analyzed by FACS. A. Treated for 2 hours and B. 24 hours 
with a Bf of 126 nM. FBS corresponded to cells where FBS was removed for 24 hours. Cells corresponded to cells with only 
Neuron Medium; Control cells were treated with 0.5 % DMSO. Results are expressed as mean ± SD of five independent 
experiments performed in duplicate. Statistical significance * p < 0.05, ** p < 0.01. 
 
Primary cerebellar granule culture 
To assess the specific effect of toxic levels of bilirubin (Bf 126 nM) on cell cycle 
progression in CGC culture, the cell cycle was evaluated on granule neurons treated for 2 
and 24 hours by FACS. Withdrawal of FBS from the culture medium for 24 hours was 
used as positive control for cell cycle arrest; five independent experiments performed in 
duplicated were made. As shown in Figure 28, when CGC were treated for 2 hours, the 
proportion of cells in G0/G1 was significantly increased (from 73 % to 84 %, p < 0.01), 
while cells in S phase decreased from 20 % to 11 % (p < 0.01). The percentage of cells in 
the latest cell cycle phase (G2/M) was slightly decreased. No difference was found 
between cells (kept in medium) and controls (medium with 0.5 % DMSO). No 
differences were found on the cell cycle profile after 24 hours of treatment with a 126 nM 
Bf. 
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Figure 28: Cell cycle progression in CGC primary cultures analyzed by FACS. A. Treated for 2 hours and B. 24 hours with a 
Bf of 126 nM. Cells corresponded to cells with only Neuron Medium; Control cells were treated with 0.5 % DMSO. Results 
are expressed as mean ± SD of five independent experiments performed in duplicate. Statistical significance ** p < 0.01. 
 
4.2.5 Apoptosis/ necrosis analysis in astrocyte primary culture 
To study the possible role of UCB in the induction of apoptosis and/ or necrosis, 
astrocytes were grown for 14 div and treated for 2 and 24 hours with a 126 nM Bf, and 
evaluated as described in materials and methods by FACS. 
As shown in Figure 29, no significant differences were found at any time between 
controls and treated astrocytes. Treatment of astrocytes with 0.5 % DMSO (controls) has 
not any effect on the apoptotic rate respect to cells that were kept in Neuron Medium. 
Only a slight increase in cells at early apoptosis was observed after 24 hours of treatment 
with UCB. 
A. B. 
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Figure 29: Effect of UCB on apoptosis/ necrosis induction on astrocytes primary cultures analyzed by FACS. Representative 
Annexin-V vs. Pi dot plot. The lower left quadrant correspond to normal cells (alive); lower right to cells in early apoptosis; 
the upper left to necrotic cells and the upper right to cells in late apoptosis. A. Treated for 2 and B. 24 hours with a Bf of 126 
nM. Control cells were treated with 0.5 % DMSO. Results are expressed as mean ± SD of four independent experiments 
performed in duplicate. No statistical significance were found. 
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4.3 Neural cells cryopreservation 
Proportion of cryoprotective agent 
The effect of increasing concentrations of DMSO as cryoprotective agent was 
investigated by the evaluation of cell viability (tryphan blue exclusion test) after 
rewarming, and according to how many days cells remains viable in culture. The CGC 
cultures were monitored daily to check their progress. 
 
As shown in Table 5, the viability after rewarming increased with the quantity of 
DMSO added to the medium. However only cells that were cryopreserved with less than 
20 % DMSO attached to the plate the day after plating. Furthermore, cryopreserved cells 
with 9, 15 and 16.6 % DMSO attached to the plate exhibited a rounded refringent shape 
without any kind of branching (axons), and were not able to live more than 48 hours. 
Only the cells cryopreserved with 10 % DMSO were able to adhere to the plate, develop 
and survive up to 7 div. Based on these results the following cryopreservations were 
performed with 10 % DMSO. 
 
% DMSO Viability before freezing % Viability after rewarming % 
9.0 98.0 82.8 
10.0 96.6 77.3 
15.0 94.8 84.0 
16.6 98.0 85.7 
23.1 97.9 91.9 
28.6 97.9 92.9 
Table 5: Effect of the quantity of cryoprotective agent (DMSO) added for cryopreservation on cell viability after rewarming. 
For 9.0, 16.6, 23.1, and 28.6 % one independent experiment was performed. For 10.0 % and 15.0 % three independent 
experiments were performed in triplicate. 
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Freezing and rewarming conditions 
The cerebellar granule cells were cryopreserved in Neuron Medium with 10 % DMSO 
at different freezing rates. From the temperature vs. time graph (Figure 30 A) the 
temperature and the time at which each sample spontaneously freeze was calculated for 
each cryopreserved sample (Table 6). 
 
 
Sample Freezing rate (°C/ min) 
Spontaneous 
freezing time (min) 
Freezing Temperature (°C) 
S1 3.3 12 -14.8 
S2 2.1 18 -17.1 
S3 1.2 33 -16.7 
Table 6: Freezing conditions. Each sample was frozen in triplicate. 
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Figure 30: Representative graph used for evaluation and calculation of A. Freezing rate and B. Rewarming rate. 
 
As described in materials and methods, the 3 aliquots cryopreserved from each sample 
(sample S1, S2 and S3) were thawed under different temperature (36, 39°C and RT) and 
the rewarming temperature and rate calculated, as shown in Figure 30 B. The viability 
after rewarming was evaluated by trypan blue exclusion test, and CGC cultures were 
monitored daily to check their progress and survival (days in vitro, div) (Table 7). 
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Sample 
Rewarming temperature 
(°C) 
Rewarming rate (°C/ min) Viability (%) Div 
S1a 36.0 263.0 71.8 3 
S1b 39.0 147.8 75.6 3 
S1c Air/ RT 94.1 81.8 3 
S2a 36.0 133.6 74.1 7 
S2b 39.0 154.4 83.6 7 
S2c Air/ RT 125.2 76.2 7 
S3a 36.0 101.5 75.7 6 
S3b 39.0 182.1 68.0 6 
S3c Air/ RT 282.0 80.0 6 
Table 7: Rewarming conditions, viability and survival of CGC after rewarming. Div: days in vitro. 
 
All the granule neurons that were cryopreserved with 10 % of DMSO, adhered to the 
plate and developed axons the day after plating, as fresh cells. The aliquots with lower 
survival rate derived from the sample cryopreserved with the highest freezing rate (S1). 
The survival of the cells cultures from S2 and S3 samples were almost the same. However, 
the highest viability was found in the aliquot S2b, cells cryopreserved at an average speed 
and rewarmed in a 39°C bath. The culture obtained from sample S2b showed an 
appearance more similar to cultures obtained from fresh cells. 
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5 DISCUSSION 
 
5.1 Bilirubin effect on cell cycle 
in vivo 
Since its discovery the Gunn rat has been used as animal model of CNIS and neonatal 
hyperbilirubinemia (Schutta and Johnson, 1967; Chowdhury et al., 1993). Homozygous 
hyperbilirubinemic jj Gunn rats manifest an inherited deficiency of hepatic UDP-
glucuronosyltransferase and are therefore unable to adequately conjugate and excrete bilirubin, 
developing a severe hyperbilirubinemia and visible jaundice within 6 h of parturition 
(Johnson et al., 1959; Wennberg, 1993). 
In hyperbilirubinemic jj animals, cerebellar cell proliferation appears to be affected by 
bilirubin (Schutta and Johnson, 1967; Sawasaki et al., 1976). A significantly reduction on 
cerebellar weight in jj rats respect to the normal’s heterozygous (Jj) and homozygous (JJ) 
littermates (Schutta and Johnson, 1967; Gazzin et al., 2011; Zarattini et al., 2011) have been 
demonstrated. This cerebellar hypoplasia is accompanied by prominent loss and degeneration 
of Purkinje cells and granule neurons (Mikoshiba et al., 1980; O'Callaghan and Miller, 1985; 
Chowdhury et al., 1993). Finally, the loss of cells, both in vivo and in vitro, has been linked to 
the bilirubin induced activation of apoptotic or necrotic pathways (Silva et al., 2001; 
Rodrigues et al., 2002a; Watchko, 2006; Falcao et al., 2007; Vaz et al., 2010; Rice and 
Shapiro, 2005). 
Recently alterations of the cell cycle by high concentrations of bilirubin has been 
described (Ollinger et al., 2005; Ollinger et al., 2007b; Ollinger et al., 2007a; Rao et al., 2006). 
Furthermore, in vitro evidences indicates that cell cycle regulating proteins are involved in 
apoptotic process in neurons (Herrup and Busser, 1995; Becker and Bonni, 2004; Wen et al., 
2005). 
Those studies suggested a possible link between cell cycle arrest at high concentration 
of bilirubin and the well characterized cerebellar hypoplasia in jj Guun rat. 
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Our results in whole cerebella dissected from hyperbilirubinemic (jj) Gunn rats, show a 
decrease in the protein expression of Cylin D1, Cyclin A, A1, and even more a decrease of the 
constitutively expressed Cdk2, these results are in agreement with previous in vitro findings 
(Ollinger et al., 2005; Ollinger et al., 2007b), reinforcing the capacity of bilirubin to interfere 
with the cell cycle. 
Cyclin D1 is the earliest mRNA/protein that has to be synthesized to initiate the cell 
cycle, followed by the inactivation of retinoblastoma protein (Rb) and the release of E2F 
transcription factor (Sherr and Roberts, 1999; Olashaw and Pledger, 2002). The release of 
E2F leads to the synthesis firstly of Cyclin E and later of Cyclin A, which sequentially binds 
and activates Cdk2. Therefore, the down regulation of cyclin D1 mRNA observed in jj 
animals could implicate that in some way bilirubin is interfering with the arrival of 
physiologic growth mitogenic stimulus, leading to a decrease in the rate of the cell cycle 
progression. 
This assumption is confirmed by the decrease of the protein expression of Cdk2 
observed in jj animals, key regulator of the S phase and catalytic subunit of both Cyclin E and 
Cyclin A/Cdk2 complexes. Being these two complexes required for entry into and completion 
of S phase (Pagano et al., 1992; Resnitzky and Reed, 1995; Lavia and Jansen-Durr, 1999; 
Chibazakura et al., 2011). No differences between jj and JJ Cdk2 mRNA levels were 
observed, indicating that the reduction plays across post-transcriptional mechanism(s). 
In the past, bilirubin has been considered able to impair both protein and DNA synthesis, 
and this has been suggested as a possible explanation for the cerebella hypoplasia observed in 
hyperbilirubinemic Gunn rats (Yamada et al., 1977; Katoh-Semba and Kashiwamata, 1984). 
However, we report a relevant increase in Cyclin E mRNA and protein in jj animals (vs. JJ). 
This results, in addition to the significant increase in the protein level of αTubulin observed in 
jj animals (p < 0.01; data not shown) are not in line with this theory. 
The up-regulation of Cyclin E we observed in vivo, do not correlate with the down-
regulation of Cyclin E reported in literature (Ollinger et al., 2005) and seems not to be in line 
with the idea that bilirubin arrests the cell cycle. However, in the hyperbilirubinemic cerebella, 
the higher levels of the total Cyclin E protein were basically due to an increase in the amounts 
of the LMW isoforms, whereas the protein expression of the FL form was unchanged. The 
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LMW isoforms of Cyclin E are generated through cleavage by the elastase class of proteases 
from the FL Cyclin E (Harwell et al., 2000; Porter and Keyomarsi, 2000; Porter et al., 2001). 
Additionally, when in complex with Cdk2, they are biochemically hyperactive as compared 
with FL Cyclin E/CDK2 complex (Porter and Keyomarsi, 2000; Wingate et al., 2003; Harwell 
et al., 2004). Moreover, it has been shown that Cyclin E can functionally replace Cyclin D1 
deficiency (Geng et al., 1999). Therefore, we hypothesized that the increased expression of 
LMW isoforms in jj Gunn rats, could be an attempt to bypass the cell cycle arrest, by an hyper 
activation of the remained Cdk2, and the induction of a faster rate of cell cycle progression 
and proliferation (Porter and Keyomarsi, 2000; Harwell et al., 2000). 
Despite this supposed effort to overcome the arrest of the cell cycle, we still observed a 
cell cycle arrest in the late G0/G1 phase in whole cerebella of hyperbilirubinemic pups by 
FACS (Figure 18). These in vivo results are in agreement, with those reported in vitro by 
other, on different cell cultures exposed to bilirubin (Rao et al., 2006; Ollinger et al., 2005; 
Ollinger et al., 2007a). It is important to bear in mind that the cerebellar cells used in this 
study are a mixture of all the type of cells found in jj cerebellum, not only those sensitive to 
bilirubin toxicity, such as neuronal cells, but also the less sensitive ones, such as glial cells. 
These less sensitive cells might partially mask the effect of bilirubin toxicity to a level similar 
to that of JJ cerebellar cells, decreasing the difference in cell cycle progression between the 
two genotypes. This assumption was confirmed when we evaluated the cell cycle progression 
in the two distinguished cells subpopulations (Subpopulation A and B), the cell cycle 
progression was not affected in Subpopulation A, while the decrease observed in 
Subpopulation B was greater than that observed in the whole suspension; unfortunately we 
were unable to characterize the composition of each subpopulation. 
Most importantly, in hyperbilirubinemic Gunn rats (vs. controls), the expression of p18-
cyclin E fragment was increased. This fragment, is generated through caspase -mediated 
proteolytic cleavage of the C-terminal portion of Cyclin E, leading to the inactivation of 
Cyclin E activity and cell cycle function (Mazumder et al., 2002), due to the abrogation of its 
binding to Cdk2. In contrast to cell cycle progression, the p18-cyclin E fragment has a critical 
role in the amplification of the intrinsic apoptotic pathway, by interacting with Ku70, p18-
Cyclin E release Bax, which participates in the amplification of apoptosis (Mazumder et al., 
2007b; Mazumder et al., 2007a). The caspase mediated apoptotic cell death is accomplished 
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through the cleavage of several key proteins required for cellular functioning and survival 
(Fischer et al., 2003). One of them is PARP-1, Poly (ADP-ribose) polymerase-1, and the 
presence of its cleaved form (cPARP, 85 kDa fragment) is considered to be a hallmark of 
apoptosis (Kaufmann et al., 1993; Tewari et al., 1995). Previously it has been demonstrated in 
vitro that bilirubin treatment of rat neurons produce cytochrome c release, caspase-3 
activation, PARP cleavage and apoptosis (Rodrigues et al., 2002a). The detection of cleaved 
PARP in the cerebellum of P9 normal (JJ) hyperbilirubinemic (jj) Gunn rat indicates, as we 
expected, the presence of an apoptotic process. The levels of cleaved PARP observed in 
normal animals correspond to the physiological cell death (apoptosis) observed during 
cerebellar development (Cheng et al., 2011; Oppenheim, 1991). While the increased levels of 
PARP and cleaved PARP in hyperbilirubinemic jj Gunn rat (vs. JJ) indicates an enhancement 
of the apoptotic process by the high levels of bilirubin present in this animals. 
 
in vitro 
Numerous studies have demonstrated the selectivity of the bilirubin toxicity for certain 
areas of the brain and for only certain cells types within them. It has been shown that 
neurons, particularly granule neurons and Purkinje cells (Schutta and Johnson, 1967; 
Takagishi and Yamamura, 1989; Sawasaki et al., 1976), are the main target for bilirubin 
toxicity (Danbolt et al., 1993; Hansen et al., 1988b; Sawasaki et al., 1976; Ngai et al., 
2000; Vazquez et al., 1988), recent reports have also described compromised astrocyte 
function following UCB interaction (Silva et al., 1999; Silva et al., 2002; Amit and 
Brenner, 1993). The cerebellum of hyperbilirubinemic Gunn rat presents degeneration 
and loss of Purkinje cells, reduction of the granular layer thickness, and hypertrophy of 
astrocytes (Chowdhury et al., 1993; Mikoshiba et al., 1980; O'Callaghan and Miller, 1985; 
Sawasaki et al., 1976). 
Our results in primary cultures of cerebellar astrocytes and granule cells shown that 
cell viability was only affected when bilirubin treatment was performed with a toxic 
concentration (about of 140 nM Bf, such as that found in P9 hyperbilirubinemic Gunn 
rat), and this effect was time-dependent. Granule neurons were more susceptible than 
astrocytes, showing a decrease in cell viability at shorter treatment times than astrocytes. 
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These results are in agreement with previous studies performed with higher bilirubin 
concentrations in neuronal cells lines or primary cultures (Notter and Kendig, 1986; Ngai 
et al., 2000; Rodrigues et al., 2002c; Silva et al., 2002). When we evaluated the rate of 
apoptosis in astrocytes after treatment, we did not observe significant difference (as 
respect to controls). Our results of bilirubin-induced apoptosis in astrocytes differ from 
the previously cited studies; this could be due to that they were made with higher UCB 
concentrations and longer treatment periods. 
Additionally, when we evaluated the cell cycle progression in the two primary cultures 
we observed a different cell response to UCB- induced toxicity. The cell cycle was 
arrested only in granule cells after two hours of UCB exposure, while, after 24 hours of 
treatment the cell cycle arrest had disappeared. As far as we know, this is the first study 
showing that bilirubin affects the cell cycle differently in astrocytes and granular cells. 
Also, our result showing that the cell cycle is only arrested in granular cells, further 
reinforce the fact that neurons are far more sensitive than astrocytes when exposed to the 
same insult (same UCB concentration and treatment time). To study the molecular 
mechanism underneath we evaluated the gene expression of the same cell cycle 
regulators used in the in vivo study. No conclusive information could be taken from these 
results, because the bilirubin vehicle (DMSO) alone affected the gene expression of 
Cyclin D1 and A in granule cells at every treatment time. In astrocytes DMSO affect the 
gene expression of cylin D1 and A1 only at longer (24) hours of treatment. 
 
in vivo- in vitro 
The in vivo cell cycle analysis of the whole pool of cells that constitute the cerebellum 
indicates a cell cycle arrest in the cerebellum of hyperbilirubinemic Gunn rats respect to 
controls. Moreover, when the two main subpopulations detected were evaluated 
independently, a cell cycle arrest was observed in only one of them, Subpopulation B, 
while the other one (Subpopulation A) did not differ. When primary cell cultures of 
astrocytes and granular neurons, obtained from whole cerebellum, were treated with an 
UCB concentration (about 140 nM Bf) similar to that found in hyperbilirubinemic P9 
Gunn pups, an arrest of the cell cycle was observed only in granular cell culture. If we put 
DISCUSSION 
74 
 
together the in vivo and in vitro results, we could speculate that Subpopulation B is 
mainly constitute by sensitive granular cells, while Subpopulation A by astrocytes. 
Further experiments, using specific cell markers, have to be performed to characterise the 
two subpopulations, and confirm our hypothesis. 
 
5.2 Cryopreservation of primary granule neurons 
With the beginning of success in neural tissue transplantation the studies of 
cryopreservation of neural cells/tissue started to growth. Several studies have been 
performed to achieve cryopreservation of nervous tissue, cells, primary neural tissue, 
neural progenitors cells and neural stem cells have been subjected to freezing, as 
summarized by Paynter in 2008 (Paynter, 2008; Ichikawa et al., 2007). However, for 
these cells type cryopreservation has not been applied with sufficient success to enable it 
to be incorporated into routine clinical practice. 
In our attempts to cryopreserve cerebellar granule cells by the slow- freezing 
methodology, we observed that with increasing concentrations of cryoprotective agent 
(DMSO) the cell viability after rewarming was higher, however cells were unable to 
attach to the plate. The best results were obtained with 10 % DMSO (although the 
viability was of 77.3 %), a middle freezing rate of 2.1°C/min and a faster rewarming rate 
(154.4°C/min) at 39°C bath. Further experiments must be done to check neuronal 
function. 
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6 CONCLUSION 
 
In conclusion, our in vivo data indicate that in jj Gunn rat cerebellum high level of 
unconjugated bilirubin causes a cell cycle arrest, the enhancement of apoptosis. This two 
processes seem to be active through p18-Cyclin E. Thus the combination of cell cycle 
arrest and apoptosis could be the cause of the cerebellar hypoplasia observed in 
hyperbilirubinemic jj Gunn rat. 
 
Collectively our in vitro data support the selectivity of bilirubin to damaged specific 
cells as cerebellar granule neurons. Cerebellar granule cells were more susceptible to 
bilirubin toxicity than astrocytes, and in agreement the cell cycle was only affected in 
granule cells. This last result could indicate that the cell cycle arrest observed in vivo may 
be caused mainly by granule cells arrest. 
 
Cryopreservation of cerebellar granule cells was successful when 10 % DMSO was 
used as cryoprotective agent, the freezing of the sample was made at a middle rate, and 
rewarmed at a fast rate. 
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